Medicare Program; Final Waivers in Connection With the Shared Savings Program, 67992-68010 [2011-27460]
Download as PDF
67992
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Chapter IV
Office of Inspector General
42 CFR Chapter V
[CMS–1439–IFC]
RIN 0938–AR30
Medicare Program; Final Waivers in
Connection With the Shared Savings
Program
Centers for Medicare &
Medicaid Services (CMS) and Office of
Inspector General (OIG), HHS.
ACTION: Interim final rule with comment
period.
AGENCY:
This interim final rule with
comment period establishes waivers of
the application of the Physician SelfReferral Law, the Federal anti-kickback
statute, and certain civil monetary
penalties (CMP) law provisions to
specified arrangements involving
accountable care organizations (ACOs)
under section 1899 of the Social
Security Act (the Act) (the Shared
Savings Program), including ACOs
participating in the Advance Payment
Initiative. Section 1899(f) of the Act, as
added by the Affordable Care Act,
authorizes the Secretary to waive certain
fraud and abuse laws as necessary to
carry out the provisions of section 1899
of the Act.
DATES: Effective date: These regulations
are effective on November 2, 2011.
Comment date: To be assured
consideration, comments must be
received at one of the addresses
provided below, no later than 5 p.m. on
January 3, 2012. Because of the large
number of public comments we
normally receive on Federal Register
documents, we are not able to
acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified here, and, when we
proceed with a subsequent document,
we will respond to the comments in the
preamble to that document.
ADDRESSES: In commenting, please refer
to file code CMS–1439–IFC. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
You may submit comments in one of
four ways (please choose only one of the
ways listed)
mstockstill on DSK4VPTVN1PROD with RULES3
SUMMARY:
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address only: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–1439–IFC, P.O. Box 8013,
Baltimore, MD 21244–8013.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address only: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–1439–IFC,
Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1813.
4. By hand or courier. Alternatively,
you may deliver (by hand or courier)
your written comments only to the
following addresses prior to the close of
the comment period:
a. For delivery in Washington, DC—
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, Room 445–G, Hubert
H. Humphrey Building, 200
Independence Avenue, SW.,
Washington, DC 20201.
(Because access to the interior of the
Hubert H. Humphrey Building is not
readily available to persons without
Federal government identification,
commenters are encouraged to leave
their comments in the CMS drop slots
located in the main lobby of the
building. A stamp-in clock is available
for persons wishing to retain a proof of
filing by stamping in and retaining an
extra copy of the comments being filed.)
b. For delivery in Baltimore, MD—
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
If you intend to deliver your
comments to the Baltimore address, call
telephone number (410) 786–1066 in
advance to schedule your arrival with
one of our staff members.
Comments erroneously mailed to the
addresses indicated as appropriate for
hand or courier delivery may be delayed
and received after the comment period.
For information on viewing public
comments, see the beginning of the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Neal Shah (410) 786–1167 or Kristin
Bohl (410) 786–8680, for general
issues and issues related to the
Physician Self-Referral Law.
James A. Cannatti III (202) 619–0335, for
general issues and issues related to
PO 00000
Frm 00002
Fmt 4701
Sfmt 4700
the Federal anti-kickback statute or
civil monetary penalties.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following Web
site as soon as possible after they have
been received: https://
www.regulations.gov. Follow the search
instructions on that Web site to view
public comments.
Comments received timely will be
also available for public inspection as
they are received, generally beginning
approximately 3 weeks after publication
of a document, at the headquarters of
the Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Baltimore, Maryland 21244, Monday
through Friday of each week from
8:30 a.m. to 4 p.m. To schedule an
appointment to view public comments,
phone 1–800–743–3951.
I. Introduction and Overview
Section I. of this interim final rule
with comment period (IFC) provides an
introduction and overview of this rule.
Section II. of this IFC provides
background on the Shared Savings
Program. Section III. of this IFC
summarizes public comments received
in response to the Waiver Designs
Notice and Shared Savings Program
proposed rule (as those terms are
defined below). Section IV. of this IFC
sets out the waivers and applicable
requirements. Section V. of this IFC
explains the waivers and solicits
comments on specific ways we might
modify the waivers to address fraud and
abuse or other problems that may arise.
A. Connection Between Shared Savings
Program and Fraud and Abuse Waivers
Elsewhere in this issue of the Federal
Register, the Centers for Medicare &
Medicaid Services (CMS) published a
final rulemaking setting forth the
requirements for ACOs under the
Shared Savings Program (hereinafter
referred to as the ‘‘Shared Savings
Program final rule’’). Section 1899 of the
Act (as added by section 3022 of the
Patient Protection and Affordable Care
Act (Pub. L. 111–148), as amended by
the Health Care and Education
Reconciliation Act of 2010 (Pub. L. 111–
152) (collectively, the ‘‘Affordable Care
Act’’) describes the Shared Savings
Program as a Medicare program to
promote accountability for a Medicare
patient population, coordinate items
E:\FR\FM\02NOR3.SGM
02NOR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
and services under Parts A and B, and
encourage investment in infrastructure
and redesigned care processes for high
quality and efficient service delivery. As
described in the Shared Savings
Program final rule, the Shared Savings
Program is designed to achieve three
goals: Better health for populations,
better care for individuals, and lower
growth in expenditures. CMS’s
expectation is that Shared Savings
Program accountable care organizations
(ACO) 1 will help foster a new approach
to delivering care that reduces
fragmented or unnecessary care and
excessive costs for Medicare fee-forservice beneficiaries and other patients.
The Physician Self-Referral Law, the
Federal anti-kickback statute, and the
civil monetary penalties (CMP) law
provisions addressing inducements to
beneficiaries and hospital payments to
physicians to reduce or limit services,
described in greater detail elsewhere in
this IFC, are some of the important tools
used to protect patients and the Federal
health care programs from fraud,
improper referral payments,
unnecessary utilization,
underutilization, and other harms.
However, stakeholders have expressed
concern that the restrictions these laws
place on certain arrangements between
physicians, hospitals, and other
individuals and entities may impede
development of some of the innovative
integrated-care models envisioned by
the Shared Savings Program. Section
1899(f) of the Act authorizes the
Secretary to waive these and certain
other laws as necessary to carry out the
Shared Savings Program. Based on
stakeholder input and other factors, the
Secretary has found that it is necessary
to waive these fraud and abuse laws in
order to carry out the Shared Savings
Program.
Accordingly, this IFC sets forth
waivers of certain provisions of the
Physician Self-Referral Law, the Federal
anti-kickback statute, the CMP law
prohibiting hospital payments to
physicians to reduce or limit services
(the Gainsharing CMP), and the CMP
law prohibiting inducements to
beneficiaries (the Beneficiary
Inducements CMP) as necessary to carry
out the provisions of section 1899 of the
Act. We seek to waive application of
these fraud and abuse laws to ACOs
formed in connection with the Shared
Savings Program so that the laws do not
unduly impede development of
beneficial ACOs, while also ensuring
1 For purposes of this IFC, the terms ‘‘ACO,’’
‘‘ACO participants,’’ and ‘‘ACO providers/
suppliers’’ have the meanings ascribed to them in
42 CFR 425.20.
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
that ACO arrangements are not misused
for fraudulent or abusive purposes that
harm patients or Federal health care
programs.
The waivers set forth in this IFC are
promulgated pursuant to the specific
authority at section 1899(f) of the Act.
This authority applies only to the
Shared Savings Program and to all
ACOs participating in the Shared
Savings Program. This includes those
Shared Savings Program ACOs that are
also participating in the Advance
Payment Initiative to be administered by
the Center for Medicare & Medicaid
Innovation (Innovation Center). The
Affordable Care Act includes separate
authority for the Secretary to waive
fraud and abuse laws for certain other
demonstrations and pilot programs.
Guidance regarding such waivers will
be issued separately.
B. Overview of Final Waivers
On April 7, 2011, CMS and OIG
jointly published a notice with
comment period seeking public
comment on certain proposed waivers
and other waiver design considerations
(Waiver Designs in Connection with the
Shared Savings Program and the
Innovation Center (76 FR 19655))
(hereinafter referred to as the ‘‘Waiver
Designs Notice’’). In that same issue of
the Federal Register, CMS published a
proposed rulemaking setting forth
proposed requirements for ACOs under
the Shared Savings Program (Shared
Savings Program: Accountable Care
Organizations (76 FR 19528))
(hereinafter referred to as the ‘‘Shared
Savings Program proposed rule’’) and
soliciting public comments.
CMS and OIG are jointly establishing
waivers under this IFC to provide
stakeholders with a coordinated
approach to the waivers of fraud and
abuse laws in connection with the
Shared Savings Program.
Administration of the Physician SelfReferral Law is the responsibility of
CMS; the OIG is responsible for
enforcement of the CMP provisions
under the Physician Self-Referral Law.
OIG shares responsibility for the Federal
anti-kickback statute with the
Department of Justice. The Gainsharing
CMP and Beneficiary Inducements CMP
are administered by the OIG.
For reasons elaborated in more detail
elsewhere in this IFC, the Secretary has
determined, based on consideration of
public input and the Department’s own
analysis, that it is necessary to waive
certain provisions of the Physician SelfReferral Law, the Federal anti-kickback
statute, the Gainsharing CMP, and the
Beneficiary Inducements CMP in some
PO 00000
Frm 00003
Fmt 4701
Sfmt 4700
67993
circumstances to carry out the Shared
Savings Program.
Section IV. of this IFC sets out the
specific waivers and the conditions
pertaining to them. Section V. of this
IFC provides commentary explaining
the waivers and solicits comments on
possible modifications. There are five
waivers addressing different
circumstances—
• An ‘‘ACO pre-participation’’ waiver
of the Physician Self-Referral Law, the
Federal anti-kickback statute, and the
Gainsharing CMP that applies to ACOrelated start-up arrangements in
anticipation of participating in the
Shared Savings Program, subject to
certain limitations, including limits on
the duration of the waiver and the types
of parties covered;
• An ‘‘ACO participation’’ waiver of
the Physician Self-Referral Law, the
Federal anti-kickback statute, and the
Gainsharing CMP that applies broadly to
ACO-related arrangements during the
term of the ACO’s participation
agreement under the Shared Savings
Program and for a specified time
thereafter;
• A ‘‘shared savings distributions’’
waiver of the Physician Self-Referral
Law, Federal anti-kickback statute, and
Gainsharing CMP that applies to
distributions and uses of shared savings
payments earned under the Shared
Savings Program;
• A ‘‘compliance with the Physician
Self-Referral Law’’ waiver of the
Gainsharing CMP and the Federal antikickback statute for ACO arrangements
that implicate the Physician SelfReferral Law and meet an existing
exception; and
• A ‘‘patient incentive’’ waiver of the
Beneficiary Inducements CMP and the
Federal anti-kickback statute for
medically related incentives offered by
ACOs under the Shared Savings
Program to beneficiaries to encourage
preventive care and compliance with
treatment regimes.
These waivers include the two
waivers proposed in the Waiver Designs
Notice (the shared savings distributions
waiver and the compliance with the
Physician Self-Referral Law waiver), as
well as three new waivers developed in
response to public comments seeking
additional pathways to address a
broader array of ACO activities needed
to achieve the purposes of the Shared
Savings Program. These five waivers
provide flexibility for ACOs and their
constituent parts to pursue a wide array
of activities, including start-up and
operating activities that further the
purposes of the Shared Savings
Program. These waivers incorporate
conditions that, in combination with
E:\FR\FM\02NOR3.SGM
02NOR3
67994
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
additional safeguards in the Shared
Savings Program final rule, are intended
to protect Medicare beneficiaries and
the Medicare program from fraud and
abuse while furthering the quality,
economy, and efficiency goals of the
Shared Savings Program.
An arrangement need only fit in one
waiver to be protected; parties seeking
to ensure that an arrangement is covered
by a waiver for a particular law may
look to any waiver that applies to that
law. In some cases, an arrangement may
meet the criteria of more than one
waiver.
mstockstill on DSK4VPTVN1PROD with RULES3
II. Shared Savings Program:
Background
A. Section 1899 of the Social Security
Act
Section 1899 of the Act establishes
the Shared Savings Program to
encourage the development of ACOs in
Medicare. The Shared Savings Program
is one of the first initiatives
implemented under the Affordable Care
Act aimed specifically at improving
‘‘value’’ in the Medicare program—that
is, both higher quality and lower total
expenditures for individual Medicare
beneficiaries and the Medicare program.
Section 1899 of the Act encourages
ACOs to promote accountability for
individual Medicare beneficiaries and
population health management,
improve the coordination of patient care
under Parts A and B, and encourage
investment in infrastructure and
redesigned care processes for high
quality and efficient service delivery.
Redesigned care processes may improve
care, increase efficiency, and lower
costs for Medicare and other patients
served by the ACO.
In accordance with the Shared
Savings Program final rule, ACOs will
enter into a participation agreement
with the Secretary to participate in the
Shared Savings Program for no less than
a 3-year period under one of two tracks.
Under the first track, an ACO will have
the opportunity to share in savings
generated during the agreement. Under
the second track, ACOs will operate
under a ‘‘two-sided risk’’ model in
which they will be eligible to receive a
higher share of savings, but will also be
required to repay a portion of the losses
sustained by the Medicare program if
costs for the ACO’s assigned
beneficiaries exceed certain thresholds.
Under either model, in order to share a
percentage of achieved savings with the
Medicare program, ACOs must
successfully meet quality and savings
requirements and certain other
conditions under the Shared Savings
Program. ACO participants and ACO
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
providers/suppliers will continue to
receive fee-for-service payments, and,
under the Shared Savings Program, the
ACO legal entity may choose how it
distributes shared savings or allocates
risk among its ACO participants and its
ACO providers/suppliers. ACOs in the
Shared Savings Program must also
comply with requirements addressing
governance, management, and
leadership of the ACO, as well as
program integrity, transparency,
compliance plan, and certification
requirements, among others.
B. Waiver Authority Under Section
1899(f) of the Act
Section 1899(f) of the Act provides
that ‘‘[t]he Secretary may waive such
requirements of sections 1128A and
1128B and title XVIII of [the] Act as may
be necessary to carry out the provisions
of [section 1899 of the Act].’’ This
waiver authority is specific to the
Shared Savings Program, and does not
apply to other similar integrated-care
delivery models. We may consider
waivers (where authorized under the
Affordable Care Act), exceptions, or safe
harbors, as applicable, for other types of
accountable care organizations,
integrated-care delivery models, or
arrangements at a later date. As
explained in section V. of this IFC, any
waivers for Innovation Center
demonstration programs, apart from the
Advance Payment Initiative, will be
issued separately under the relevant
authority.
We note that a waiver of a specific
fraud and abuse law is not needed for
an arrangement to the extent that the
arrangement: (1) Does not implicate the
specific fraud and abuse law; or (2)
implicates the law, but either fits within
an existing exception or safe harbor, as
applicable, or does not otherwise violate
the law. Arrangements that do not fit in
a waiver have no special protection and
must be evaluated on a case-by-case
basis for compliance with the Physician
Self-Referral Law, the Federal antikickback statute, and the CMP laws.
Failure to fit in a waiver is not, in and
of itself, a violation of the laws. Existing
exceptions and safe harbors might apply
to ACO arrangements, depending on the
circumstances.2 These include, among
others, Physician Self-Referral Law
exceptions for employment, personal
services arrangements, in-office
ancillary services, electronic health
records (EHR) arrangements, risksharing, and indirect compensation
arrangements (to the extent an ACO
arrangement is an indirect financial
2 42
CFR 411.355 through 411.357; 42 CFR
1001.952; 42 CFR 1003.110.
PO 00000
Frm 00004
Fmt 4701
Sfmt 4700
relationship). Potential Federal antikickback statute safe harbors include,
among others, those for employment,
personal services and management
contracts, EHR arrangements, and
managed care arrangements.
The waiver authority under section
1899(f) is limited to sections 1128A and
1128B and title XVIII of the Act, and
does not extend to any other laws or
regulations, including, without
limitation, the Internal Revenue Code
(IRC) or State laws and regulations.
Accordingly, nothing in this IFC affects
the obligations of individuals or entities,
including tax-exempt organizations, to
comply with the IRC or other Federal or
State laws and regulations. Moreover,
nothing in this IFC changes any
Medicare program reimbursement or
coverage rule or alters any obligations
parties may have under the Shared
Savings Program. Although the waivers
described in this IFC are necessary to
ensure that the fraud and abuse laws do
not unduly impede development of
ACOs in connection with the Shared
Savings Program, the waivers are not
intended to suggest that any particular
arrangement between particular parties
is necessary to implementing the Shared
Savings Program.
C. Fraud and Abuse Laws—Background
1. Physician Self-Referral Law (Section
1877 of the Act)
Section 1877 of the Act (42 U.S.C.
1395nn, the ‘‘Physician Self-Referral
Law’’) is a civil statute that prohibits
physicians from making referrals for
Medicare ‘‘designated health services,’’
including hospital services, to entities
with which they or their immediate
family members have a financial
relationship, unless an exception
applies. These entities may not bill
Medicare for services rendered as a
result of a prohibited referral, and
section 1877(g)(1) of the Act states that
no payment may be made for a
designated health service that is
furnished pursuant to a prohibited
referral. CMPs also apply to any person
who presents (or causes to be presented)
a bill for services for which he or she
knows or should know payment may
not be made under section 1877(g)(1) of
the Act. For additional details, see
section 1877(g)(3) of the Act. Violations
of the Physician Self-Referral Law may
also result in liability under the False
Claims Act (31 U.S.C. 3729–33).
2. The Federal Anti-Kickback Statute
(Section 1128B(b) of the Act)
Section 1128B(b) of the Act (42 U.S.C.
1320a–7b(b), the ‘‘Federal anti-kickback
statute’’) provides criminal penalties for
E:\FR\FM\02NOR3.SGM
02NOR3
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
individuals or entities that knowingly
and willfully offer, pay, solicit, or
receive remuneration to induce or
reward the referral of business
reimbursable under any of the Federal
health care programs, as defined in
section 1128B(f) of the Act. The offense
is classified as a felony and is
punishable by fines of up to $25,000
and imprisonment for up to 5 years.
Violations of the Federal anti-kickback
statute may also result in the imposition
of CMPs under section 1128A(a)(7) of
the Act (42 U.S.C. 1320a–7a(a)(7)),
program exclusion under section
1128(b)(7) of the Act (42 U.S.C. 1320a–
7(b)(7)), and liability under the False
Claims Act (31 U.S.C. 3729–33). Certain
practices that meet all of the conditions
of a safe harbor at 42 CFR 1001.952 are
not subject to prosecution or sanctions
under the Federal anti-kickback statute.
mstockstill on DSK4VPTVN1PROD with RULES3
3. Prohibition on Inducements to
Beneficiaries (Section 1128A(a)(5) of the
Act)
Section 1128A(a)(5) of the Act (42
U.S.C. 1320a–7a(a)(5)), the ‘‘Beneficiary
Inducements CMP’’) prohibits
individuals and entities from offering or
transferring remuneration to Medicare
or Medicaid beneficiaries that the
individual or entity knows or should
know is likely to influence the
beneficiary to order or receive from a
particular provider, practitioner, or
supplier any Medicare or Medicaid item
or service. There are existing exceptions
to the Beneficiary Inducements CMP at
section 1128A(i)(6) of the Act.
4. Prohibition on Hospital Payments to
Physicians To Induce Reduction or
Limitation of Services (Sections
1128A(b)(1) and (2) of the Act)
Sections 1128A(b)(1) and (2) of the
Act (42 U.S.C. 1320a–7a(b)(1) and (2),
the ‘‘Gainsharing CMP’’) apply to
certain payment arrangements between
hospitals and physicians, including
arrangements commonly referred to as
‘‘gainsharing’’ arrangements. Under
section 1128A(b)(1) of the Act, a
hospital is prohibited from making a
payment, directly or indirectly, to
induce a physician to reduce or limit
services to Medicare or Medicaid
beneficiaries under the physician’s
direct care. Hospitals that make (and
physicians who receive) such payments
are liable for CMPs of up to $2,000 per
patient covered by the payments
(sections 1128A(b)(1) and (2) of the Act).
D. Summary of Public Input
Opportunities
Since passage of the Affordable Care
Act, the U.S. Department of Health and
Human Services (DHHS) has offered
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
numerous opportunities for the public
to provide input into the design and
operation of ACOs and waivers
necessary to carry out the provisions of
the Shared Savings Program, most
recently through the Waiver Designs
Notice described previously in this IFC.
In addition, CMS issued a Request for
Information Regarding Accountable
Care Organizations and the Shared
Saving Program on November 10, 2010,3
and held multiple listening sessions
with stakeholders. CMS, OIG, and the
Federal Trade Commission held a joint
workshop on October 5, 2010, entitled
‘‘Workshop Regarding Accountable Care
Organizations, and Implications
Regarding Antitrust, Physician SelfReferral, Anti-Kickback, and Civil
Monetary Penalty (CMP) Laws.’’ 4 We
also received and reviewed written
public comments in connection with the
workshop.5 Finally, we received public
comments related to the waivers in
response to the Waiver Designs Notice
and the Shared Savings Program
proposed rule. Through these means,
DHHS has received public input
representing a wide spectrum of views.
E. Contents of Waiver Designs Notice
The Waiver Designs Notice proposed
several waivers related to ACOs in the
Shared Savings Program and also
solicited public comments on a range of
issues. The proposed waivers included
waivers of certain provisions of the
Physician Self-Referral Law and the
Federal anti-kickback statute to
distributions of shared savings received
by an ACO from CMS under the
Medicare Shared Savings Program: (1)
To or among ACO participants, ACO
providers/suppliers, and individuals
and entities that were ACO participants
or ACO providers/suppliers during the
year in which the shared savings were
earned by the ACO; or (2) for activities
necessary for and directly related to the
ACO’s participation in and operations
under the Shared Savings Program. We
also proposed to waive certain
provisions of the Federal anti-kickback
statute with respect to any financial
relationship between or among the
ACO, ACO participants, and ACO
providers/suppliers necessary for and
directly related to the ACO’s
participation in and operations under
the Medicare Shared Savings Program
that implicates the Physician SelfReferral Law and fully complies with an
3 75
FR 70165 (2010).
about the workshop is available on
CMS’s Web site at https://www.cms.gov/center/
physician.asp.
5 The public comments are available on the FTC’s
Web site at https://www.ftc.gov/os/comments/aco/
index.shtm.
4 Information
PO 00000
Frm 00005
Fmt 4701
Sfmt 4700
67995
exception at 42 CFR 411.355 through
411.357.
We also proposed to waive certain
provisions of the Gainsharing CMP with
respect to two scenarios: (1)
Distributions of shared savings received
by an ACO from CMS under the
Medicare Shared Savings Program in
circumstances where the distributions
are made from a hospital to a physician,
provided that the payments are not
made knowingly to induce the
physician to reduce or limit medically
necessary items or services, and the
hospital and physician are ACO
participants or ACO providers/
suppliers, or were ACO participants or
ACO providers/suppliers during the
year in which the shared savings were
earned by the ACO; and (2) any
financial relationship between or among
the ACO, its ACO participants, and its
ACO providers/suppliers necessary for
and directly related to the ACO’s
participation in and operations under
the Medicare Shared Savings Program
that implicates the Physician SelfReferral Law and fully complies with an
exception at 42 CFR 411.355 through
411.357.
The Waiver Designs Notice
recognized that the proposed waivers
might not cover all of the possible
arrangements involved with setting up
and operating an ACO. As such, we
solicited comments on waivers,
modifications, or additions that would
be necessary to carry out the provisions
of the Shared Savings Program. We
specifically solicited comments on how
waivers should address: arrangements
related to establishing the ACO;
arrangements between or among ACO
participants and/or ACO providers/
suppliers related to ongoing operations
of the ACO and achieving ACO goals;
other arrangements for which a waiver
would be necessary; the duration of the
waivers; and the scope of the waivers.
III. Summary of Public Comments to
the Waiver Designs Notice and Relevant
Sections of the Shared Savings Program
Proposed Rule
We received comments related to the
proposed waivers and solicitation of
comments on other waiver design
considerations in response to both the
Waiver Designs Notice and the Shared
Savings Program proposed rule. We
summarize the comments in this section
of the IFC. Section V. of this IFC
explains the waivers in more detail and
responds to comments.
A. Threshold Qualifications for Waiver
Commenters requested that we clarify
whether we will be issuing waivers that
are uniform across all ACOs
E:\FR\FM\02NOR3.SGM
02NOR3
67996
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
participating in the Shared Savings
Program. At least one commenter
recommended that we retain some
provision for individualized review
while others requested that waivers
apply uniformly to all participants.
mstockstill on DSK4VPTVN1PROD with RULES3
B. Scope of Proposed Waivers
We received numerous comments
about the appropriate scope of the
waivers. The great majority of
commenters supported broader waivers.
Many of those commenters indicated
that the proposed waivers would be
insufficient to foster the innovation and
relationships necessary for participation
in the Shared Savings Program.
However, some commenters expressed
concern that the proposed waivers were
too broad, or that expanded waivers
could lead to program abuses.
1. General Issues
Many commenters stated that the
applicable fraud and abuse laws should
be waived in their entirety for ACOs
participating in the Shared Savings
Program because, according to the
commenters, the laws are premised on
a ‘‘fee-for-service’’ world that has
different incentives than those that
apply to the Shared Savings Program
and because the Shared Savings
Program incorporates monitoring,
reporting, and other program features
that will act as safeguards. These
commenters stated that DHHS should
waive these laws for entities that
successfully enter and participate in the
Shared Savings Program, such that the
entities would be shielded from
penalties for transactions related to ACO
business. Many commenters stated that
certain elements of the Physician SelfReferral Law exceptions and Federal
anti-kickback statute safe harbors cannot
sufficiently support the development of
innovative ACO structures. For
example, these commenters identified
the ‘‘transaction-by-transaction’’
structure of the existing exceptions and
safe harbors and the ‘‘fair market value’’
or ‘‘set in advance’’ elements of many of
them as specific burdens.
Several commenters stated that the
fraud and abuse laws should be waived
for payments between ACOs enrolled in
the Shared Savings Program, their ACO
participants, and/or their ACO
providers/suppliers, regardless of the
source of funding for the payments.
Some commenters asserted that the
Shared Savings Program’s standards for
clinical integration should justify
protection for payments other than
shared savings distributions, if the
payments are made in service of
achieving Shared Savings Program
goals. Others were concerned that the
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
continued use of fee-for-service
payments in the program created an
incentive for overutilization.
The majority of comments generally
suggested one of two broad approaches
to waiving the laws: First, an ‘‘ACO
waiver’’ establishing broad protections
for ACO functions, or second, a total
waiver of the laws for any ACO
participating in the Shared Savings
Program. Many commenters called for
the agencies to create an ‘‘ACO waiver’’
that would cover ACO activities through
the lifespan of an ACO, from
arrangements leading up to formation of
the ACO, through the end of the ACO’s
participation in the program. Other
commenters advocated the creation of a
‘‘single, comprehensive approach’’ for
compliance, rather than requiring a
piecemeal transaction-by-transaction
analysis. Some commenters requested
‘‘blanket’’ waivers for certain categories
of remuneration, including nonmonetary arrangements (such as IT
services, EHR systems, and the
provision of free care management
personnel and/or services) and
‘‘systems-level’’ activities (such as
medical directorships or infection
prevention/antimicrobial stewardship
programs).
In contrast, a minority of commenters
favored waivers no broader or narrower
than the proposed waivers. Some of
these commenters advocated alternate
approaches including: Different
safeguards (discussed later in this IFC),
waivers conditioned on certain
qualitative limits, and more extensive
monitoring (including monitoring of
beneficiary access to care and costshifting to private insurers). Although
some commenters were concerned about
an overly broad waiver and cautioned
against expanding beyond the proposed
waiver designs, the majority of
commenters believed the proposed
waiver for shared savings distributions
would be too narrow, particularly
because an ACO, its ACO participants,
and its ACO providers/suppliers will
not have access to the shared savings
distributions until long after the ACO
has entered into its participation
agreement, thus precluding use of those
savings to fund start-up and operating
activities.
Some commenters raised issues
related to specific scenarios. For
example, a commenter requested that
ACOs with ‘‘commercial motives’’ be
treated differently than ACOs composed
of ‘‘public health providers’’ because,
according to the commenter, the latter
do not give rise to similar fraud and
abuse concerns. Other commenters
stated that the fraud and abuse laws
presented a particular challenge for
PO 00000
Frm 00006
Fmt 4701
Sfmt 4700
prospective ACOs in States with
‘‘corporate practice of medicine’’ laws
because providers and suppliers could
not satisfy certain important exceptions
and safe harbors (including the
employment exception and safe harbor)
in those States.
We also received requests for
clarification about the proposed
waivers. Several commenters requested
clarification about how the fraud and
abuse laws would interact with specific
Shared Savings Program rules. For
example, one commenter expressed
concern about the phrase ‘‘distributions
of shared savings,’’ and asked the
agencies to clarify whether a payment
from an ACO to its ACO participants or
its ACO providers/suppliers must be
conditioned on the same quality and
cost terms that govern the ACO’s
participation agreement (or whether it
would be sufficient that the payment
initially comes from shared savings). We
also received a number of comments on
the proposed ‘‘necessary for and directly
related to’’ standard. Commenters
overwhelmingly requested that we
clarify this phrase, arguing it was too
restrictive and thus did not provide
sufficient assurance that ACOs could
participate in the Shared Savings
Program. Some commenters believed
the standard was overly broad, with one
expressing concern that the standard
could allow arrangements that would
eliminate competition. Some
commenters requested concrete
examples of relationships that would
meet this standard, while others
requested that the agencies allow greater
flexibility. Commenters also suggested a
range of different standards, including,
for example, mandating that
relationships simply be ‘‘related’’ or
‘‘directly related’’ to the ACO, making
the standard subjective, or requiring
payments to entities outside the ACO to
be linked to quality improvement goals.
Finally, some commenters stated that it
would be difficult to isolate
arrangements that are ‘‘necessary for
and directly related to’’ the ACO
because many arrangements will only be
feasible if applied to all payers and/or
patients.
Some commenters also raised
questions about how the waivers would
function practically. For example, one
commenter asked whether all ACO
participants or ACO providers/suppliers
would endanger their Medicare fee-forservice payments if the ACO (or one of
its ACO participants or ACO providers/
suppliers) fails to satisfy one of the
qualifications of the waiver. We also
received many requests for clarification
of the scope of the waiver for shared
savings distributions. For example,
E:\FR\FM\02NOR3.SGM
02NOR3
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
some commenters asked us to confirm
that downstream distributions would be
covered by the waiver, while others
asked us to clarify whether repayment
of start-up costs out of shared savings
would be considered ‘‘necessary for and
directly related to’’ the ACO’s
participation in the program.
mstockstill on DSK4VPTVN1PROD with RULES3
2. Compliance With the Physician SelfReferral Law Waiver
We received several comments asking
for clarification of the proposed waiver
of the Federal anti-kickback statute and
Gainsharing CMP for financial
relationships between or among the
ACO, ACO participants, and ACO
providers/suppliers necessary for and
directly related to the ACO’s
participation in and operations under
the Shared Savings Program that
implicate the Physician Self-Referral
Law and fully comply with an existing
exception at 42 CFR 411.355 through
411.357. Several commenters requested
expansion of this waiver to cover
relationships that would not implicate
the Physician Self-Referral Law either
because the relationship would not
involve designated health services or
would not involve referring physicians
covered by the Physician Self-Referral
Law. While commenters on this topic
generally welcomed the alignment of
the Federal anti-kickback statute, the
Gainsharing CMP, and the Physician
Self-Referral Law for ACO
arrangements, some expressed concern
that the proposed waiver design was too
limited to promote many innovative
ACO arrangements.
3. Gainsharing CMP
Some commenters requested
clarification of the application of the
waiver of the Gainsharing CMP. For
example, some commenters asked us to
confirm that distributions of shared
savings made from the ACO to a
physician would be protected, even if
the ACO is owned in part by a hospital.
Some commenters urged us to adopt a
narrow waiver of the Gainsharing CMP
and to carefully monitor ACOs to ensure
that the waiver does not lead to a
reduction or limitation of medically
necessary services. Many commenters
requested additional clarification of the
‘‘medically necessary’’ standard that
limited application of the proposed
waiver of the Gainsharing CMP to
arrangements that do not reduce
medically necessary care. Several
commenters asked us to clarify or
confirm whether reliance on evidencebased protocols would be sufficient to
meet the ‘‘medically necessary’’
standard. Several commenters noted
that successful ACOs may reduce some
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
types of medically necessary services by
encouraging the use or ordering of
alternative medically necessary services,
for example, arrangements that
incentivize reductions in emergency
room visits by encouraging management
of conditions on a non-emergency basis
or arrangements that reduce inpatient
admissions in favor of coordinated
outpatient care. A commenter urged us
to permit financial rewards that incent
implementation of evidence-based
treatment protocols, even though such
payments may be intended to encourage
clinicians to select one type of
medically necessary service over
another.
C. Duration of Waivers
Commenters generally objected to the
proposed requirement that the waivers
would apply only so long as an ACO, its
ACO participants, and its ACO
providers/suppliers remained in
compliance with Shared Savings
Program requirements. Some
commenters requested that this
requirement be eliminated and replaced
by a simpler threshold for waiver
qualification, asserting that the auditing
and oversight functions at the outset of
and during the Shared Savings Program
are sufficient to protect against fraud
and abuse.
Many commenters requested that the
waivers cover periods prior to an ACO’s
acceptance into the Shared Savings
Program. Some of these commenters
also expressed a desire that the waivers
cover time periods after the ACO, its
ACO participants, and its ACO
providers/suppliers have left the Shared
Savings Program, for purposes of
winding down the arrangement or
otherwise ensuring continued
compliance with the laws. One
commenter suggested that the waivers
cover a period of at least 24 months
prior to the start of any agreement with
CMS, with no possibility of retroactive
enforcement, in order to avoid a chilling
effect on innovation. Other commenters
suggested that the agencies apply the
waivers to payments whenever made, if
the payments relate to activities leading
up to or occurring within the agreement
period.
D. Additional Waiver Design
Considerations
1. Start-Up Costs
Many commenters stated that the
fraud and abuse laws should be waived
in a manner that allows participants to
finance others’ start-up costs. As
examples, commenters identified:
Infrastructure creation and provision
prior to acceptance in the Shared
PO 00000
Frm 00007
Fmt 4701
Sfmt 4700
67997
Savings Program (for example, care
coordination mechanisms; EHR systems;
data reporting systems; new staff; and
systems to make operational
performance measurements and allocate
performance results and payments
accordingly); market analysis for
antitrust purposes; potential novel
arrangements created to facilitate
integration across multiple
organizations; organizational and
training costs; incentives to attract
primary care physicians; and any loans,
capital contributions, grants and
withholds.
Some commenters suggested that
waivers covering start-up costs should
be limited to providers that have a
financial stake in the success of the
ACO, or, absent this requirement, that
any waiver should be limited to
distributions of shared savings only.
2. Other Arrangements Among the ACO,
Its ACO Participants, and Its ACO
Providers/Suppliers
Most commenters on this topic stated
that waivers should cover arrangements
(in addition to those arising out of
shared savings) among the ACO, its
ACO participants, and its ACO
providers/suppliers. One commenter
recommended that the waivers not
apply to additional arrangements unless
the arrangements are necessary for or
directly related to the ACO’s operations
under the Shared Savings Program. But
the majority of commenters, supporting
a broader approach to waivers,
explained that waivers for other
arrangements are necessary to allow for
start-up, operating, and maintenance
costs in the context of innovative
arrangements. These commenters had
various suggestions about how the laws
should be waived. As noted previously,
many commenters suggested that the
fraud and abuse laws should be waived
broadly for ACOs in the Shared Savings
Program. Others suggested that the laws
should be waived for compensation that
is expressly conditioned on quality
improvements, cost savings, or
adherence to objective clinical
measures, care coordination guidelines,
and/or treatment models. Others
suggested that waivers should cover
payments that are made in connection
with the operations and goals of the
ACO and are commercially reasonable.
Some commenters asked us to consider
situations in which ACOs do not
generate shared savings immediately, if
at all, and pointed to the Medicare
Physician Group Practice demonstration
project as an example. One commenter
proposed that the waiver should cover
hospitals that share the proceeds of
system-wide savings they achieve
E:\FR\FM\02NOR3.SGM
02NOR3
67998
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
outside the context of the Shared
Savings Program or some other formal
payer-organized shared savings
program.
mstockstill on DSK4VPTVN1PROD with RULES3
3. Other Arrangements With Parties
Outside the ACO
Some commenters asked us to clarify
the term ‘‘outside individuals and
entities’’ as that term was used in the
solicitation of comments on this issue.
For example, commenters asked
whether the waivers would cover
arrangements with physicians and other
providers who are not ACO participants
or ACO providers/suppliers but who
treat ACO patients and voluntarily
comply with the ACO’s policies and
procedures.
Many commenters appreciated the
proposed waiver for arrangements with
parties outside the ACO that are funded
with distributions of shared savings.
However, many commenters requested
that we expand the waiver to cover
arrangements with individuals or
entities outside the ACO even if the
payments are not derived from shared
savings. Some commenters suggested
that covered arrangements be restricted
to those that meet articulated standards
(for example, only arrangements arising
out of the distribution of shared savings
should be waived) and that CMS
monitor referrals to ensure that nonACO participants and non-ACO
providers/suppliers are not being
unfairly marginalized.
4. Relationships With Private Payers/
Other Payers
Many commenters stated that the
agencies should waive the fraud and
abuse laws for arrangements involving
payments from private payers to ACOs,
including ‘‘downstream’’ arrangements
between or among the ACO, ACO
participants, and ACO providers/
suppliers. These commenters generally
believed that limiting the waiver to
arrangements involving Medicare
shared savings would limit economies
of scale and introduce significant
complexity from the perspective of
governance and management. One
commenter argued that the involvement
of private health plans in ACO
relationships would reduce fraud and
abuse concerns. Some commenters
expressed concern that failure to
address private payer arrangements
would perpetuate uncertainty for ACOs
enrolling in the Shared Savings Program
that were also contemplating similar
arrangements with private payers. These
commenters observed that arrangements
downstream of private payer incentive
payment programs can be sensitive to
the volume or value of ‘‘other business
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
generated’’ for providers and suppliers
and thus might not fit in existing
exceptions to the Physician Self-Referral
Law. One commenter representing
health plans expressed concern about
ACO arrangements under the Shared
Savings Program that might result in
cost-shifting to private plans or steerage
of patients to or from Medicare managed
care plans based on the services
required by the patient. Some
commenters stated that we should not
create waivers for private payer
arrangements.
Some commenters suggested that, if
the final waivers do not cover
relationships with private payers, the
agencies should clarify how elements of
existing exceptions and safe harbors
may be applied to such arrangements
involving ACOs. For example,
commenters requested further
clarification on the following: whether
hospital distribution of a private payer’s
shared savings payments would
constitute ‘‘indirect compensation’’
under the Physician Self-Referral Law;
how to calculate ‘‘fair market value’’ of
downstream distributions of private
payer shared savings for purposes of
applicable exceptions; and whether the
Physician Self-Referral Law risk-sharing
exception could be used. Finally, one
commenter requested that the agencies
integrate guidance for private payers
with guidance for other non-Medicare
payers, including Medicaid.
5. Appropriate Safeguards
Some commenters stated that
safeguards beyond the transparency,
accountability, and oversight
protections built into the Shared
Savings Program proposed rule are
unnecessary because such safeguards
adequately address patient and program
abuse. A commenter stated that
providing opportunities for creativity
without waiver-specific, restrictive
safeguards will not increase the
likelihood that individuals or
organizations will place their own
financial interests above those of their
patients; instead, it will allow them to
focus on furnishing appropriate and
necessary care coordination. A
commenter suggested that safeguards be
based on prior OIG advisory opinions or
the CMS proposed incentive payment
and shared savings exception.
Other commenters believed that
additional safeguards are necessary and
suggested, for example, requiring
arrangements to meet a fair market value
or commercial reasonableness standard;
requiring additional disclosures to CMS
and to patients; or imposing more
specific requirements related to
methods for distributing shared savings
PO 00000
Frm 00008
Fmt 4701
Sfmt 4700
to address the commenters’ concerns
about distributions inappropriately
influencing physician ordering patterns
or possible stinting on care.
A commenter stated that the waiver
for shared savings distributions should
not protect distributions of shared
savings from an ACO to an ACO
participant on the basis of that ACO
participant’s generation of other
business for another ACO participant.
Some commenters suggested monitoring
of referrals outside the ACO to detect
improper referral patterns. One
commenter requested that CMS create a
system to continually assess the
compliance of an ACO, its ACO
participants, and its ACO providers/
suppliers with the fraud and abuse laws.
6. Two-Sided Risk
We received several comments in
response to our solicitation on waiver
considerations related to two-sided risk.
One commenter noted that a waiver
should apply equally to both one- and
two-sided risk models. Other
commenters recommended that CMS
either extend the proposed waiver to
cover hospitals’ disproportionate
assumption of risk or change the Shared
Savings Program proposed rule to make
the two-sided option voluntary or make
it clear that such assumption of risk is
not remuneration under the Physician
Self-Referral Law. Commenters asked
that we protect the means or allocation
of shared savings and losses, and that
we define the ‘‘proper’’ allocation of
such savings or losses.
7. Existing Exception and Safe Harbor
for Electronic Health Records
We sought comments in the Waiver
Designs Notice addressing whether, in
connection with the Shared Savings
Program, we should use the authority at
section 1899(f) of the Act to waive the
Physician Self-Referral Law and the
Federal anti-kickback statute for ACO
arrangements that satisfy the existing
exception and safe harbor 6 for EHR
arrangements but that are expected to
occur after the sunset date of 2013.
Some commenters requested that the
agencies waive the current sunset date
of 2013 that applies to the existing EHR
exception and safe harbor, and
suggested that the agencies protect the
EHR arrangements of ACOs in the
Medicare Shared Savings Program after
2013 on the same terms as the existing
exception and safe harbor. Some
commenters particularly argued that the
Shared Savings Program proposed rule’s
standard of 50 percent meaningful use
6 42 CFR 411.357(w) and 42 CFR 1001.952(y),
respectively.
E:\FR\FM\02NOR3.SGM
02NOR3
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
of EHRs demonstrated the need to
extend the waiver to relationships
intended to reach that standard.
One commenter disagreed with
waiving the EHR exception and safe
harbor and suggested rescinding the
exception and safe harbor or specifically
excluding these types of arrangements
from the waiver, because the EHR
incentive in American Recovery and
Reinvestment Act of 2009 was sufficient
to achieve the exception’s and safe
harbor’s original purpose of promoting
adoption of technology. However, most
commenters addressing this topic
requested that we make the exception
and safe harbor permanent, extend them
for several years, or protect ACOs at any
time after the sunset on the same terms
as the exception and safe harbor.
8. Beneficiary Inducements
Most commenters addressing this
topic supported a waiver of the
Beneficiary Inducements CMP, section
1128A(a)(5) of the Act, although some of
them expressed opposition. Among
commenters supporting a waiver, many
cited the need for a waiver to promote
greater preventive care, to incentivize
patients to follow treatment or followup care regimes, and to increase
participation in ACOs in order to
achieve the goals of the Shared Savings
Program. Several supporters of a waiver
suggested that the waiver cover reduced
or eliminated beneficiary cost-sharing,
or other financial incentives, such as
allowing beneficiaries to share in ACO
cost savings. Commenters opposing a
Beneficiary Inducements CMP waiver
stated it could negatively impact patient
choice by promoting incentives that
might induce beneficiaries to seek care
only within a particular ACO.
mstockstill on DSK4VPTVN1PROD with RULES3
9. Timing of Waivers
Generally, commenters supported
issuance of the waivers prior to or at the
same time as the Shared Savings
Program final rule in order to afford
prospective ACOs, their ACO
participants, and ACO providers/
suppliers as much time as possible to
prepare for application to the Shared
Savings Program with known waiver
protection.
10. Other Issues Related to Shared
Savings Program Waivers
Commenters raised a number of other
issues related to the waivers. Some
commenters requested that the waivers
apply to clinically integrated
organizations that do not participate in
the Shared Savings Program. Others
raised the issue that waivers of the
Physician Self-Referral Law, Federal
anti-kickback statute, and Gainsharing
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
CMP laws do not offer protection with
respect to State laws. Several
commenters asked the agencies to
clarify how the proposed waivers would
affect programs outside the Shared
Savings Program. Commenters proposed
that CMS should extend uniform
waivers for all Medicare projects
involving coordinated care, including
the Independence at Home project,
Bundled Payment project, and
demonstrations sponsored by the
Innovation Center. One commenter
requested that the waiver apply to
healthcare providers other than ACO
participants or ACO providers/
suppliers, while others requested that
waivers apply to all arrangements
between ACO participants and/or ACO
providers/suppliers, and individuals or
entities outside the Shared Savings
Program.
We also received a number of
comments that are outside the scope of
this rulemaking. Those comments are
not summarized here.
IV. Provisions of the Interim Final Rule
With Comment Period: Waiver
Requirements
A. Overview
Section IV.B. of this IFC sets forth the
specific waivers and waiver
requirements, pursuant to the authority
granted under section 1899(f) of the Act.
The waivers apply only to the specific
provisions of the laws enumerated in
the waivers and do not apply to any
other provisions of Federal or State law,
including, without limitation, any
provisions of the IRC. We invite the
public to comment on the waivers set
forth in section IV.B. of this IFC.
To promote efficiency and ease of use,
we crafted the waivers to apply
consistently across the waived fraud
and abuse laws to the extent possible.
The waivers apply uniformly to each
ACO, ACO participant, and ACO
provider/supplier (as those terms are
defined in section IV.B. of this IFC
pursuant to the Shared Savings
Program) participating in the Shared
Savings Program. The waivers are
intended to be self-implementing. Apart
from meeting applicable waiver
conditions, no special action (such as
the submission of a separate application
for a waiver) is required by parties in
order to be covered by a waiver. Parties
need not apply for an individualized
waiver.
This IFC includes five waivers. The
multiplicity of waivers is intended to
afford flexibility to ACOs in varying
circumstances and to be responsive to
public comments outlining a wide
variety of arrangements that ACOs of
PO 00000
Frm 00009
Fmt 4701
Sfmt 4700
67999
various types might need to undertake
in order to be successful at carrying out
the Shared Savings Program. While the
waivers contain many common
elements, there are distinctions among
them tailored to address particular
circumstances, including particular
fraud and abuse risks. The first two
waivers are an ACO pre-participation
waiver and an ACO participation waiver
that should, collectively, address the
majority of ACO-related start-up and
operating arrangements identified by
public comments and the DHHS’s own
analysis as necessary to carry out the
Shared Savings Program. Two
additional waivers—for shared savings
distributions and arrangements that are
in compliance with the Physician SelfReferral Law—were described in the
Waiver Designs Notice and are being
established in this IFC with minor
modifications. Many arrangements
covered by these waivers could also be
protected under the ACO preparticipation and ACO participation
waivers. However, some parties may
find these two additional waivers more
suitable to their particular needs, and
we have elected to make them available.
The remaining waiver addresses
incentives offered to beneficiaries to
foster preventive health care and patient
compliance with treatment regimes in
order to engage patients in quality and
care improvement. For ease of reference,
the entire set of waivers and applicable
requirements is set forth in section IV.B.
of this IFC. We will also make the
waiver text available on both the CMS
and OIG Web sites. Because the waivers
cover multiple legal authorities and to
ensure that the waivers, if modified,
remain consistent over time and across
relevant laws, we are not codifying the
waivers in the Code of Federal
Regulations. We solicit comments about
this approach.
Additional explanation appears in
section V. of this IFC, as well as
additional solicitations of comments on
possible modifications to the waiver
designs.
B. The Waivers and Applicable
Requirements
As used in these waivers, ACO, ACO
participant, and ACO provider/supplier
have the meanings set forth in 42 CFR
425.20. In the context of the ACO preparticipation waiver, these terms refer to
individuals or entities that would meet
the definitions of the terms set forth in
42 CFR 425.20, if the ACO had a
participation agreement, but for the fact
that the ACO has not yet submitted the
list required under 42 CFR 425.204(c)(5)
to be provided with the application for
the Shared Savings Program.
E:\FR\FM\02NOR3.SGM
02NOR3
mstockstill on DSK4VPTVN1PROD with RULES3
68000
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
As used in these waivers,
participation agreement refers to the
agreement between an ACO and CMS
for the ACO’s participation in the
Shared Savings Program that is
described in 42 CFR 425.208.
As used in these waivers, purposes of
the Shared Savings Program means one
or more of the following purposes
consistent with section 1899(a) and (b)
of the Act: promoting accountability for
the quality, cost, and overall care for a
Medicare patient population as
described in the Shared Savings
Program, managing and coordinating
care for Medicare fee-for-service
beneficiaries through an ACO, or
encouraging investment in
infrastructure and redesigned care
processes for high quality and efficient
service delivery for patients, including
Medicare beneficiaries.
As used in these waivers, start-up
arrangements means any items,
services, facilities, or goods (including
non-medical items, services, facilities,
or goods) used to create or develop an
ACO that are provided by such ACO,
ACO participants, or ACO providers/
suppliers.
ACO Pre-participation Waiver.
Pursuant to section 1899(f) of the Act,
section 1877(a) of the Act (relating to
the Physician Self-Referral Law),
sections 1128A(b)(1) and (2) of the Act
(relating to the Gainsharing CMP), and
sections 1128B(b)(1) and (2) of the Act
(relating to the Federal anti-kickback
statute) are waived with respect to startup arrangements that pre-date an ACO’s
participation agreement, provided all of
the following conditions are met:
1. The arrangement is undertaken by
a party or parties acting with the good
faith intent to develop an ACO that will
participate in the Shared Savings
Program starting in a particular year (the
‘‘target year’’) and to submit a
completed application to participate in
the Shared Savings Program for that
year. The parties to the arrangement
must include, at a minimum, the ACO
or at least one ACO participant of the
type eligible to form an ACO (as set
forth at 42 CFR 425.102(a)). The parties
to the arrangement may not include
drug and device manufacturers,
distributors, durable medical equipment
(DME) suppliers, or home health
suppliers.
2. The parties developing the ACO
must be taking diligent steps to develop
an ACO that would be eligible for a
participation agreement that would
become effective during the target year,
including taking diligent steps to meet
the requirements of 42 CFR 425.106 and
425.108 concerning the ACO’s
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
governance, leadership, and
management.
3. The ACO’s governing body has
made and duly authorized a bona fide
determination, consistent with a duty to
the ACO that is equivalent to the duty
owed by ACO governing body members
under 42 CFR 425.106(b)(3), that the
arrangement is reasonably related to the
purposes of the Shared Savings
Program.
4. The arrangement, its authorization
by the governing body, and the diligent
steps to develop the ACO are
documented. The documentation of the
arrangement must be contemporaneous
with the establishment of the
arrangement, the documentation of the
authorization must be contemporaneous
with the authorization, and the
documentation of the diligent steps
must be contemporaneous with the
diligent steps. All such documentation
must be retained for at least 10 years
following completion of the
arrangement (or, in the case of the
diligent steps, for at least 10 years
following the date the ACO submits its
application or the date the ACO submits
its statement of reasons for failing to
submit an application, as described in
item 6) and promptly made available to
the Secretary upon request. The
documentation must identify at least the
following:
a. A description of the arrangement,
including all parties to the arrangement;
the date of the arrangement; the
purpose(s) of the arrangement; the
items, services, facilities, and/or goods
covered by the arrangement (including
non-medical items, services, facilities,
or goods); and the financial or economic
terms of the arrangement.
b. The date and manner of the
governing body’s authorization of the
arrangement. The documentation of the
authorization should include the basis
for the determination by the ACO’s
governing body that the arrangement is
reasonably related to the purposes of the
Shared Savings Program.
c. A description of the diligent steps
taken to develop an ACO, including the
timing of actions undertaken and the
manner in which the actions relate to
the development of an ACO that would
be eligible for a participation agreement.
5. The description of the arrangement
is publicly disclosed at a time and in a
place and manner established in
guidance issued by the Secretary. Such
public disclosure shall not include the
financial or economic terms of the
arrangement.
6. If an ACO does not submit an
application for a participation
agreement by the last available
application due date for the target year,
PO 00000
Frm 00010
Fmt 4701
Sfmt 4700
the ACO must submit a statement on or
before the last available application due
date for the target year, in a form and
manner to be determined by the
Secretary, describing the reasons it was
unable to submit an application.
For arrangements that meet all of the
preceding conditions, the preparticipation waiver applies as follows:
• The waiver period would start on—
++ The date of publication of this IFC
for target year 2012; or
++ One year preceding an application
due date (the ‘‘selected application
date’’) for a target year of 2013 or later.
• The waiver period would end—
++ For ACOs that submit an
application by the selected application
date and enter into a participation
agreement for the target year, on the
start date for that agreement;
++ For ACOs that submit an
application by the selected application
date for the target year, but whose
application is denied, on the date of the
denial notice, except with respect to any
arrangement that qualified for the
waiver before the date of the denial
notice, in which case the waiver period
would end on the date that is 6 months
after the date of the denial notice; and
++ For ACOs that fail to submit an
application by the selected application
due date for the target year, on the
earlier of the selected application due
date or the date the ACO submits a
statement of reasons for failing to
submit an application, except that an
ACO that has been unable to submit an
application, but can demonstrate a
likelihood of successfully developing an
ACO that would be eligible to
participate in the Shared Savings
Program by the next available
application due date, may apply for an
extension of the waiver, pursuant to
procedures to be established by the
Secretary in guidance. The
determination whether to grant a waiver
will be in the sole discretion of the
Secretary and will not be reviewable.
++ An ACO may use the preparticipation waiver (including any
extensions granted) only one time.
ACO Participation Waiver. Pursuant
to section 1899(f) of the Act, section
1877(a) of the Act (relating to the
Physician Self-Referral Law), sections
1128A(b)(1) and (2) of the Act (relating
to the Gainsharing CMP), and sections
1128B(b)(1) and (2) of the Act (relating
to the Federal anti-kickback statute) are
waived with respect to any arrangement
of an ACO, one or more of its ACO
participants or its ACO providers/
suppliers, or a combination thereof,
provided all of the following conditions
are met:
E:\FR\FM\02NOR3.SGM
02NOR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
1. The ACO has entered into a
participation agreement and remains in
good standing under its participation
agreement.
2. The ACO meets the requirements of
42 CFR 425.106 and 425.108 concerning
its governance, leadership, and
management.
3. The ACO’s governing body has
made and duly authorized a bona fide
determination, consistent with the
governing body members’ duty under 42
CFR 425.106(b)(3), that the arrangement
is reasonably related to the purposes of
the Shared Savings Program.
4. Both the arrangement and its
authorization by the governing body are
documented. The documentation of the
arrangement must be contemporaneous
with the establishment of the
arrangement, and the documentation of
the authorization must be
contemporaneous with the
authorization. All such documentation
must be retained for at least 10 years
following completion of the
arrangement and promptly made
available to the Secretary upon request.
The documentation must identify at
least the following:
a. A description of the arrangement,
including all parties to the arrangement;
date of the arrangement; the purpose of
the arrangement; the items, services,
facilities, and/or goods covered by the
arrangement (including non-medical
items, services, facilities, or goods); and
the financial or economic terms of the
arrangement.
b. The date and manner of the
governing body’s authorization of the
arrangement. The documentation
should include the basis for the
determination by the ACO’s governing
body that the arrangement is reasonably
related to the purposes of the Shared
Savings Program.
5. The description of the arrangement
is publicly disclosed at a time and in a
place and manner established in
guidance issued by the Secretary. Such
public disclosure shall not include the
financial or economic terms of the
arrangement.
For arrangements that meet all of the
preceding conditions, the waiver period
will start on the start date of the
participation agreement and will end
6 months following the earlier of the
expiration of the participation
agreement, including any renewals
thereof, or the date on which the ACO
has voluntarily terminated the
participation agreement. However, if
CMS terminates the participation
agreement, the waiver period will end
on the date of the termination notice.
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
3. Shared Savings Distribution Waiver
Pursuant to section 1899(f) of the Act,
section 1877(a) of the Act (relating to
the Physician Self-Referral Law),
sections 1128A(b)(1) and (2) of the Act
(relating to the Gainsharing CMP), and
sections 1128B(b)(1) and (2) of the Act
(relating to the Federal anti-kickback
statute) are waived with respect to
distributions or use of shared savings
earned by an ACO, provided all of the
following conditions are met:
1. The ACO has entered into a
participation agreement and remains in
good standing under its participation
agreement;
2. The shared savings are earned by
the ACO pursuant to the Shared Savings
Program;
3. The shared savings are earned by
the ACO during the term of its
participation agreement, even if the
actual distribution or use of the shared
savings occurs after the expiration of
that agreement.
4. The shared savings are—
a. Distributed to or among the ACO’s
ACO participants, its ACO providers/
suppliers, or individuals and entities
that were its ACO participants or its
ACO providers/suppliers during the
year in which the shared savings were
earned by the ACO; or
b. Used for activities that are
reasonably related to the purposes of the
Shared Savings Program.
5. With respect to the waiver of
sections 1128A(b)(1) and (2) of the Act
(relating to the Gainsharing CMP),
payments of shared savings
distributions made directly or indirectly
from a hospital to a physician are not
made knowingly to induce the
physician to reduce or limit medically
necessary items or services to patients
under the direct care of the physician.
4. Compliance With the Physician SelfReferral Law Waiver
Pursuant to section 1899(f) of the Act,
sections 1128A(b)(1) and (2) of the Act
(relating to the Gainsharing CMP) and
sections 1128B(b)(1) and (2) of the Act
(relating to the Federal anti-kickback
statute) are waived with respect to any
financial relationship between or among
the ACO, its ACO participants, and its
ACO providers/suppliers that implicates
the Physician Self-Referral Law,
provided all of the following conditions
are met:
1. The ACO has entered into a
participation agreement and remains in
good standing under its participation
agreement.
2. The financial relationship is
reasonably related to the purposes of the
Shared Savings Program.
PO 00000
Frm 00011
Fmt 4701
Sfmt 4700
68001
3. The financial relationship fully
complies with an exception at 42 CFR
411.355 through 411.357.
For arrangements that meet all of the
preceding conditions, the waiver period
will start on the start date of the
participation agreement and will end on
the earlier of the expiration of the term
of the participation agreement,
including any renewals thereof, or the
date on which the participation
agreement has been terminated.
5. Waiver for Patient Incentives
Pursuant to section 1899(f) of the Act,
section 1128A(a)(5) of the Act (relating
to the beneficiary inducements CMP)
and sections 1128B(b)(1) and (2) of the
Act (relating to the Federal antikickback statute) are waived with
respect to items or services provided by
an ACO, its ACO participants, or its
ACO providers/suppliers to
beneficiaries for free or below fairmarket-value if all four of the following
conditions are met:
1. The ACO has entered into a
participation agreement and remains in
good standing under its participation
agreement.
2. There is a reasonable connection
between the items or services and the
medical care of the beneficiary.
3. The items or services are in-kind.
4. The items or services—
a. Are preventive care items or
services; or
b. Advance one or more of the
following clinical goals:
i. Adherence to a treatment regime.
ii. Adherence to a drug regime.
iii. Adherence to a follow-up care
plan.
iv. Management of a chronic disease
or condition.
For arrangements that meet all of the
preceding conditions, this waiver period
will start on the start date of the
participation agreement and will end on
the earlier of the expiration of the term
of the participation agreement,
including any renewals thereof, or the
date on which the participation
agreement has been terminated,
provided that a beneficiary may keep
items received before the participation
agreement expired or terminated, and
receive the remainder of any service
initiated before the participation
agreement expired or terminated.
V. Provisions of the Interim Final Rule
With Comment Period: Explanation of
Waiver Requirements
This section explains the waivers set
forth in section IV.B. of this IFC and
responds to public comments. We are
providing guidance in this section V. of
this IFC to help stakeholders interpret
E:\FR\FM\02NOR3.SGM
02NOR3
68002
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES3
the waiver requirements. We remind
readers that the waivers should be
interpreted in a reasonable manner. We
are soliciting comments about our
approach, whether we should provide
greater specificity, and, if so, how and
for which waivers and waiver
conditions.
A. Reasonably Related to the Purposes
of the Shared Savings Program
Several waivers described in section
IV.B. of this IFC require that
arrangements be ‘‘reasonably related to
the purposes of the Shared Savings
Program.’’ We have defined ‘‘purposes
of the Shared Savings Program’’
consistent with the purposes set forth in
Section 1899(a) and (b) of the Act. We
are using the statutory purposes of the
Shared Savings Program in the waiver
context because the waiver authority
speaks to carrying out the Shared
Savings Program. As used in these
waivers, the purposes of the Shared
Savings Program consist of promoting
accountability for the quality, cost, and
overall care for a Medicare population
as described in the Shared Savings
Program; managing and coordinating
care for Medicare fee-for-service
beneficiaries through an ACO; and
encouraging investment in
infrastructure and redesigned care
processes for high quality and efficient
service delivery for patients, including
Medicare beneficiaries. As further
explained in the statute and regulations,
these purposes can involve, for
example, promoting evidence-based
medicine and patient engagement;
meeting requirements for reporting on
quality and cost measures; coordinating
care, such as through the use of
telehealth, remote patient monitoring,
and other enabling technologies;
establishing clinical and administrative
systems for the ACO; meeting the
clinical integration requirements of the
Shared Savings Program; or meeting the
quality performance standards of the
Shared Savings Program. Additional
purposes consistent with the statute and
regulations include, for example,
evaluating health needs of the ACO’s
assigned population; communicating
clinical knowledge and evidence based
medicine to beneficiaries; and
developing standards for beneficiary
access and communication, including
beneficiary access to medical records.
Arrangements with similar purposes
but that are unrelated to the Shared
Savings Program are not covered by the
term ‘‘purposes of the Shared Savings
Program.’’ Arrangements that involve
care for non-Medicare patients as well
as Medicare beneficiaries are eligible for
the waiver. We interpret the purpose of
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
‘‘efficient service delivery’’ in section
1899 of the Act to include, among other
things, appropriate reduction of costs to,
or growth in expenditures of, the
Medicare program, consistent with
quality of care, physician medical
judgment, and patient freedom of
choice. The definition of ‘‘purposes of
the Shared Savings Program’’ applies
uniformly to all waivers in which it
appears.
When a waiver requires that the terms
of the arrangement be ‘‘reasonably
related to the purposes of the Shared
Savings Program,’’ the arrangement
need only be reasonably related to one
enumerated purpose, although we
would expect that many arrangements
would relate to multiple purposes.
Where a reasonable relationship exists,
it should not be difficult for parties to
articulate clearly the nexus between
their arrangement and the purposes of
the Shared Savings Program. Consistent
with our goal to foster flexibility,
adaptability, and innovation, we are not
further describing in the waiver text the
specific arrangements that will be
considered reasonably related to the
purposes of the Shared Savings Program
or providing in the waiver text a list of
acceptable arrangements. To provide
additional assurance to ACOs, we have
provided in this section V of this IFC an
illustrative, non-exhaustive list of
arrangements that constitute start-up
arrangements for purposes of the preparticipation waiver.
As described previously in this IFC,
public comments reflected significant
variation and scope of anticipated ACO
arrangements. We expect parties to
apply a reasonable interpretation of the
waiver terms. We are, however,
soliciting comments on whether we
should further define the ‘‘reasonably
related to purposes of the Shared
Savings Program’’ standard and, if so,
how. We note that we are not using the
proposed language from our Waiver
Designs Notice requiring arrangements
to be ‘‘necessary for and directly related
to ACO purposes.’’ Several public
commenters expressed concern that this
language was not clear. We believe the
language that we are using in the
waivers is simpler and addresses public
comments. We note that arrangements
that are necessary for and directly
related to the purposes of the Shared
Savings Program would be among those
that meet the ‘‘reasonably related’’
standard.
B. Eligibility for Waiver
In general, four of the five waivers set
forth in this IFC are available to protect
arrangements involving an ACO, its
ACO participants, and/or its ACO
PO 00000
Frm 00012
Fmt 4701
Sfmt 4700
providers/suppliers, if the ACO has a
participation agreement and remains in
good standing under that agreement. We
are considering whether to require
expressly that an ACO that is under a
corrective action plan (CAP) be in
compliance with the CAP as a condition
of a waiver. We solicit comments on
these requirements.
The fifth waiver, the ACO preparticipation waiver, is available for
start-up arrangements (as defined in the
waiver) provided that the ACO is
making good faith efforts to form an
ACO and to submit an application to
participate in the Shared Savings
Program, and all other conditions of the
waiver are satisfied. To qualify for the
pre-participation waiver, the parties to
the arrangement must include, at a
minimum, the ACO or at least one
individual or entity that is eligible to
form an ACO (as defined in the Shared
Savings Program final rule). In the
context of the ACO pre-participation
waiver, the terms ACO, ACO
participant, and ACO provider/supplier
refer to individuals or entities that
would meet the definitions of those
terms set forth in the Shared Savings
Program regulations at 42 CFR 425.20, if
the ACO had a participation agreement
(but for the fact that the required list
under the regulations has not yet been
submitted to CMS). Individuals or
entities that are prospective ACO
participants or ACO providers/suppliers
should be those that would be on the
list if it were to be submitted. The preparticipation waiver does not cover
arrangements involving drug and device
manufacturers, distributors, DME
suppliers, or home health suppliers.
Drug and device manufacturers and
distributors are not Medicare enrolled
suppliers and providers; DME and home
health suppliers have historically posed
a heightened risk of program abuse.
C. Pre-Participation and Participation
Waivers
1. Scope
The intent of the pre-participation
and participation waivers in this IFC is
to establish pathways to protect bona
fide ACO investment, start-up,
operating, and other arrangements that
carry out the Shared Savings Program,
subject to certain safeguards. We do not
believe it is feasible at this time to
enumerate in the waiver text specific
protected arrangements given the
anticipated wide variation in ACO
composition, size, resources, and ACO
readiness, as well as the goal of the
program to foster innovation,
adaptability, and variation in
furtherance of quality, efficiency, and
E:\FR\FM\02NOR3.SGM
02NOR3
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES3
economy. We are concerned that, given
the limitations of foresight in the
context of a new program, a fixed list
might be under-inclusive and omit
arrangements that are necessary for
bona fide ACO activities.
The pre-participation waiver covers a
broad array of start-up arrangements, as
defined in the waiver text and discussed
in this section, subject to certain
conditions. The participation waiver
covers any arrangement that meets its
conditions, including start-up
arrangements. Many commenters
observed that arrangements necessary to
develop an ACO may occur both before
and after the ACO enrolls in the Shared
Savings Program.
Consistent with views expressed by
many commenters, both the preparticipation and participation waivers
rely, as a threshold matter, on the
programmatic requirements of the
Shared Savings Program to safeguard
Medicare beneficiaries and the Medicare
program. The design of the waivers is
premised on our expectation that risks
of fraud and abuse, such as
overutilization, inappropriate
utilization, and underutilization, will be
mitigated, in the first instance, by the
Shared Savings Program design,
including, for example, the eligibility
requirements, the quality of care and
accountability provisions, and the
program integrity provisions. In these
waivers, we are adding additional
safeguards in the form of governance
responsibility, transparency, and a
documented audit trail. These points are
explained in more detail later in this
IFC. We are aiming for an approach that
will provide ACOs with flexibility,
certainty, and latitude for beneficial
innovation and variation in connection
with the new Shared Savings Program,
while also protecting Medicare
beneficiaries and the Medicare program
from fraud and abuse.
2. Start-Up Arrangements for the PreParticipation Waiver
We are limiting the pre-participation
waiver so that it applies to ‘‘start-up
arrangements.’’ We define the term startup arrangements to mean any items,
services, facilities, or goods (including
non-medical items, services, facilities,
or goods) used to create or develop an
ACO that are provided by such ACO,
ACO participants, or ACO providers or
suppliers. We also consider the
provision of a subsidy for these items,
services, facilities, or goods to be a startup arrangement. Even though the
definition of start-up arrangements is
specifically included in the preparticipation waiver, we anticipate that
many start-up arrangements will also
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
take place during the participation
phase of an ACO’s existence; those
arrangements can qualify for the
participation waiver.
Based on comments received, we
recognize that ACOs may have a
difficult time anticipating all necessary
start-up arrangements that will need
waiver protection. While we are not
providing a specific list of ACO start-up
arrangements in the waiver text, in
order to provide additional assurance to
developing ACOs, we offer additional
guidance in this section. By way of
example only, we consider the
provision of the folliowng items,
services, facilities, and goods to be startup arrangements:
(1) Infrastructure creation and
provision;
(2) Network development and
management, including the
configuration of a correct ambulatory
network and the restructuring of
existing providers and suppliers to
provide efficient care;
(3) Care coordination mechanisms,
including care coordination processes
across multiple organizations;
(4) Clinical management systems;
(5) Quality improvement mechanisms
including a mechanism to improve
patient experience of care;
(6) Creation of governance and
management structure;
(7) Care utilization management,
including chronic disease management,
limiting hospital readmissions, creation
of care protocols, and patient education;
(8) Creation of incentives for
performance-based payment systems
and the transition from fee-for-service
payment system to one of shared risk of
losses;
(9) Hiring of new staff, including:
a. Care coordinators including nurses,
technicians, physicians, and/or nonphysician practitioners;
b. Umbrella organization
management;
c. Quality leadership;
d. Analytical team;
e. Liaison team;
f. IT support;
g. Financial management;
h. Contracting;
i. Risk management;
(10) Information Technology,
including:
a. EHR systems;
b. Electronic health information
exchanges that allow for electronic data
exchange across multiple platforms;
c. Data reporting systems, including
all payer claims data reporting systems;
d. Data analytics, including staff and
systems, such as software tools, to
perform such analytic functions;
(11) Consultant and other professional
support, including:
PO 00000
Frm 00013
Fmt 4701
Sfmt 4700
68003
a. Market analysis for antitrust review;
b. Legal services;
c. Financial and accounting services;
(12) Organization and staff training
costs;
(13) Incentives to attract primary care
physicians;
(14) Capital investments including
loans, capital contributions, grants and
withholds.
In order to foster innovation and
creativity within ACOs, we recognize
that it is impossible to create an
exhaustive list of bona fide start-up
arrangements. We solicit comments on
our definition of start-up arrangements
and specifically seek input as to
whether this definition allows for
sufficient innovation in the creation and
development of ACOs.
3. Additional Safeguards
The pre-participation waiver and the
participation waiver require that the
governing body of the ACO make a bona
fide determination that the arrangement
for which waiver protection is sought is
reasonably related to the purposes of the
Shared Savings Program (as described
previously in this IFC) and that the
governing body duly authorize the
arrangement. (For the ACO participation
waiver, the governance, as well as the
leadership and management of the ACO,
must additionally be in compliance
with the applicable rules under the
Shared Savings Program final rule at
42 CFR 425.106 and 425.108.) The
intent of this requirement is to ensure
that any arrangement for which waiver
protection is sought falls under the
auspices of the ACO; is transparent
within the ACO to ACO participants
and members of the governing body;
and is integral to the ACO’s mission and
plans to effectuate its role in the Shared
Savings Program. This approach
interposes the ACO’s governing body as
an intermediary responsible, in the first
instance, for ensuring that all protected
arrangements are in furtherance of ACO
purposes and are not isolated
arrangements furthering the individual
financial or business interests of ACO
participants or ACO providers/
suppliers.
We are not specifying in the waivers
how the ACO governing body makes the
bona fide determination or duly
authorizes it. The determination and
authorization must be
contemporaneously documented.
Documentation must include the basis
for the determination that the
arrangement is reasonably related to the
purposes of the Shared Savings
Program. We note that the governing
body under the Shared Savings Program
final rule must have a meaningful
E:\FR\FM\02NOR3.SGM
02NOR3
mstockstill on DSK4VPTVN1PROD with RULES3
68004
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
conflicts of interest policy for its
members (42 CFR 425.106(d)). We are
considering, and soliciting comments
on, whether we should specify
particular methods by which governing
bodies make determinations and
authorize arrangements to ensure that
ACOs are making bona fide, meaningful
determinations and authorizations, such
that arrangements covered by these
waivers are truly furthering the interests
of the ACO as a whole in meeting the
objectives of the Shared Savings
Program. We note that the preparticipation and participation waivers
are intended to cover arrangements,
among others, in which an ACO might
receive funding or in-kind items or
services from ACO participants or ACO
providers/suppliers and, subject to an
independent ACO governing body
determination, redistribute them to
other ACO participants or ACO
providers/suppliers.
An ACO governing body must make a
bona fide determination that an
arrangement is reasonably related to the
purposes of the Shared Savings
Program. Depending on the waiver, the
ACO governing body can make this
determination for a wide range of
arrangements, including, without
limitation, start-up arrangements and
ACO operating activities, as well as
performance-based compensation
(‘‘results-based’’ compensation) that is
dependent upon achieving quality
thresholds or efficiency measures of the
Shared Savings Program. Members of
the ACO governing body would be welladvised to exercise diligence in
ensuring that arrangements are
reasonably related to one or more
purposes of the Shared Savings Program
and to articulate clearly the bases for
their determinations and authorizations.
Arrangements should be scrutinized
with care to ensure that the reasonable
relationship between an arrangement
and the purposes of the Shared Savings
Program can be clearly identified. Not
every arrangement will be reasonably
related to the purposes of the Shared
Savings Program. For example, we do
not believe that a per-referral payment
(such as, expressly paying a specialist
$500 for every referral generated by the
specialist or paying a nursing facility
staff member $100 for every patient
transported to the ACO’s hospital)
would be reasonably related to the
purposes of the Shared Savings
Program. However, by way of example
only, arrangements with specialists or
nursing facility staff members to engage
in care coordination for ACO
beneficiaries or implement evidencebased protocols could be reasonably
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
related to the purposes of the Shared
Savings Program even if the
arrangement were to reflect a likelihood
that the patient might be referred to or
within an ACO. (Importantly, parties
remain obligated to comply with the
provisions at 42 CFR 425.304(c) that
prohibit certain required referrals and
cost-shifting.)
Next, the ACO pre-participation and
ACO participation waivers require an
audit trail of contemporaneous
documentation that identifies core
characteristics of the arrangement (as
listed in the waiver text), is maintained
for 10 years, and is available to the
Secretary, upon request. We are not
specifying in the waivers any particular
form of documentation, which can be in
paper or electronic form. Notably, the
waivers do not require an agreement
signed by the parties, although such an
agreement is a best documentation
practice (and would typically be
required for compliance with the
Physician Self-Referral Law if a waiver
does not apply). The core characteristics
of the arrangement should be evident
from the documentation with sufficient
clarity that the government or another
third party reviewing the
documentation would be able to
ascertain the material terms of the
arrangement, including the information
listed in item 4 of the pre-participation
and participation waivers. Material
amendments and modifications to the
arrangement should be similarly
documented and subject to governing
body approval and disclosure. The preparticipation waiver also requires
contemporaneous documentation of the
diligent steps the parties are taking to
develop the ACO. Documentation of the
diligent steps must be retained for at
least 10 years following that date that
the ACO submits its application or the
date the ACO submits its statement of
reasons for failing to submit an
application, as described later in this
IFC. As set forth in more detail in the
Shared Savings Program final rule,
ACOs will be monitored, and we will
make periodic requests for
documentation of arrangements
protected by waivers.
The third main safeguard included in
these waivers is a transparency
requirement that requires arrangements
for which waiver protection is desired
to be publicly disclosed. The public
disclosure will include the description
of the arrangement, but shall not
include the financial or economic terms
of the arrangement. Our decision to
shield financial or economic terms from
the public transparency requirement is
premised, among other considerations,
on potential antitrust implications. (We
PO 00000
Frm 00014
Fmt 4701
Sfmt 4700
note that, while not subject to the public
transparency requirement, the financial
or economic terms of the arrangement
are among the matters that must be
documented pursuant to the
documentation requirements of the
waivers and made available to the
Secretary upon request.)
The goals of this transparency
requirement are three-fold. First, the
requirement recognizes that secrecy is
necessary for most criminal or
fraudulent conduct, and we are
declining to protect hidden
arrangements. Second, the requirement
makes information about waived
arrangements more readily available to
parties involved with the ACO,
regulators, and the public.7 Third,
transparency creates an incentive for
ACOs to exercise due diligence when
arrangements are being established to
ensure that they are waiver compliant
and otherwise consistent with the
ACO’s mission and the duty each
member of the governing body owes to
make decisions in the interests of the
ACO. We do not expect that the
disclosure requirements, to be
determined by the Secretary in
additional guidance, will be onerous.
We expect that ACOs will be able to
use the same disclosure process that
will apply to disclosure of
organizational, quality, and performance
information under the Shared Savings
Program final rule at 42 CFR 425.308.
ACOs using the pre-participation waiver
will be able to use a similar disclosure
process. We are soliciting comments on
additional methods for public
disclosure that would be minimally
burdensome, as well as the timing for
disclosures. In the latter regard, we are
considering whether to require
disclosures on a rolling basis or on a
fixed interval basis. We are also
interested in comments addressing
whether, in lieu of additional guidance,
the disclosure requirements should be
set out with greater specificity in the
waiver text. Until such time as
additional guidance is issued, parties
seeking to use the ACO preparticipation or participation waivers
should meet the disclosure requirement
by posting information identifying the
parties to the arrangement and the type
of item, service, good, or facility
provided under the arrangement on a
public Web site belonging to the ACO or
an individual or entity forming the
ACO, clearly labeled as an arrangement
for which waiver protection is sought,
within 60 days of the date of the
7 For example, currently, the government has
limited information regarding actual usage of
existing safe harbors and exceptions.
E:\FR\FM\02NOR3.SGM
02NOR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
arrangement. The Web site must include
the name of the ACO (or, if the name of
the ACO is not known, the parties
forming the ACO) and other identifying
information sufficient to allow
individuals conducting an electronic
internet search using a widely available
search engine to readily locate the Web
site.
The current design of these waivers
applies to arrangements within the ACO
(that is, between or among the ACO, its
ACO participants, and/or its ACO
providers/suppliers), as well as ACOrelated arrangements with outside
providers and suppliers, such as
hospitals, specialists, or post-acute care
facilities that might not be part of the
ACO but have a role in coordinating and
managing care for ACO patients. (The
pre-participation waiver excludes drug
and device manufacturers, distributors,
DME suppliers, and home health
suppliers.) All such arrangements must
be reasonably related to the purposes of
the Shared Savings Program. We are
soliciting comments on whether we
should modify the waivers to exclude
outside party arrangements. We are also
seeking comments on whether we
should add additional conditions to the
participation waiver—such as
conditions requiring commercial
reasonableness or fair market value or
prohibiting exclusivity—that would
apply to ACO relationships with outside
parties, such as laboratories, equipment
or supply companies, drug and device
manufacturers, or distributors or
purchasing organizations.
The waiver text sets forth specific
duration periods for the preparticipation waiver to account for the
varying circumstances of ACOs that
submit applications that are accepted,
submit applications that are rejected, or
are unable to submit an application.
These specifications are necessary to
ensure that the waiver covers only preparticipation arrangements that are
closely linked to the Shared Savings
Program. The ACO pre-participation
waiver covers arrangements undertaken
by parties acting with good faith intent
to develop an ACO that will participate
in the Shared Savings Program starting
in a particular year (the ‘‘target year’’).
For ACOs pursuing target year 2012, the
waiver period starts on the date of
publication of this IFC. For ACOs
pursuing later target years, the waiver
period would begin one year preceding
an application due date for the target
year (the ‘‘selected application date’’).
Application due dates for these years
will be established in later guidance by
CMS but, by way of illustration only, if
an application due date for target year
2014 were September 1, 2013, the ACO
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
pre-participation waiver period would
begin on September 1, 2012.
For an ACO that submits an
application and enters into a
participation agreement, the preparticipation waiver lasts until the start
date of the participation agreement, at
which point waiver protection merges
seamlessly into the participation waiver,
and no further governing body approval
is required for arrangements that had
been protected by the pre-participation
waiver. If the application is denied, the
waiver lasts until the date of the denial
notice, except that waiver protection
extends for 6 months after the date of
the denial notice for arrangements that
qualified for the waiver before the date
of the denial notice. However, no newly
created arrangements would be
protected during the 6-month period.
The waiver period will end for ACOs
that fail to submit an application on the
final application due date for the target
year. ACOs that fail to submit an
application by the final application due
date must instead submit a statement
describing the reasons the ACO failed to
submit a timely application.
ACOs that do not submit an
application for the selected application
date, may apply for an extension of the
waiver period. The ACO must submit
documentation of its diligent steps, as
required under the waiver, and make a
showing that it is likely to successfully
develop an ACO that would be eligible
to participate in the Shared Savings
Program by the next available
application due date. The Secretary will
establish procedures in guidance for the
extension process. The determination
whether to grant a waiver will be in the
sole discretion of the Secretary and will
not be reviewable. If an extension is
granted, the next available application
due date will become the selected
application date and the new waiver
period will end in accordance with the
terms of the pre-participation waiver.
An ACO may only use the preparticipation waiver one time. If an
extension is not granted, the ACO may
no longer rely on the pre-participation
waiver.
We are considering whether to further
limit the pre-participation waiver by, for
example, requiring that parties submit a
notice of intent to form an ACO;
limiting the waiver for target years after
2013 to ACOs that file applications to
enroll in the Shared Savings Program; or
curtailing the availability or scope of the
pre-participation waiver in future years
once ACO structures have become better
established.
As described previously in this IFC,
for some circumstances, the preparticipation and participation waivers
PO 00000
Frm 00015
Fmt 4701
Sfmt 4700
68005
include a 6-month ‘‘tail’’ period
applicable to protected arrangements in
existence at the time the waiver expires
or terminates; this ‘‘tail’’ period
responds to public comments urging
that waivers allow for the orderly
unwinding or restructuring of
arrangements as necessary to ensure
continued compliance with the law. The
‘‘tail’’ periods protect only arrangements
that were in place and otherwise
qualified for the waiver at the time the
waiver expires or terminates. No ‘‘tail’’
period applies to ACOs that CMS
terminates. We considered both shorter
and longer periods for the ‘‘tail’’ period
and are soliciting comments on whether
we should modify the ‘‘tail’’ periods of
the waivers.
D. Waiver for Shared Savings
Distributions
The intent behind the waiver for
shared savings distributions is to protect
arrangements created by the distribution
of shared savings within an ACO that
qualifies for the waiver, as well as
arrangements created by the use of
shared savings to pay parties outside
such an ACO if those payments are
reasonably related to the purposes of the
Shared Savings Program. This waiver
permits shared savings to be distributed
or used within the ACO in any form or
manner, including ‘‘downstream’’
distributions or uses of shared savings
funds between or among the ACO, its
ACO participants, and its ACO
providers/suppliers. This less restrictive
waiver for shared savings distributions
within the ACO is premised, in part, on
recognition that an award of shared
savings necessarily reflects the
collective achievement by the ACO and
its constituent parts of the quality,
efficiency, and cost reduction goals of
the Shared Savings Program. These
goals are consistent with interests
protected by the fraud and abuse laws.
This waiver also affords ACOs latitude
to use shared savings in arrangements
with outside parties, provided that the
arrangements are reasonably related to
the purposes of the Shared Savings
Program.
Because the payment of shared
savings by CMS to an ACO under the
Shared Savings Program may not occur
until after expiration of the ACO’s
3-year agreement, the waiver applies to
distributions and uses of shared savings
earned during the term of the
agreement, even if distributed
subsequently. Similarly, the waiver
applies to distributions of shared
savings to individuals or entities that
were ACO participants and ACO
providers/suppliers at the time the
shared savings were earned, even if they
E:\FR\FM\02NOR3.SGM
02NOR3
mstockstill on DSK4VPTVN1PROD with RULES3
68006
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
are not part of the ACO at the time of
the actual distribution.
This waiver is limited to distributions
of shared savings; all other
arrangements would still need to qualify
for one of the other waivers outlined in
section IV. of this IFC, fit in an existing
exception or safe harbor, or otherwise
comply with the laws. This waiver does
not protect distributions of shared
savings to referring physicians outside
the ACO, unless those referring
physicians are being compensated
(using shared savings) for activities that
are reasonably related to the purposes of
the Shared Savings Program or were
ACO participants or ACO providers/
suppliers during the year in which the
shared savings were earned by the ACO.
Some commenters to the Waiver
Designs Notice inquired about our
proposal, which we are adopting here,
to exclude from the shared savings
distributions waiver of the Gainsharing
CMP situations in which a payment is
made knowingly to reduce or limit
medically necessary services to patients
under the physician’s direct care. This
limitation is consistent with the quality
and patient care goals of the Shared
Savings Program and must be
interpreted in that context. In the
context of waivers designed to carry out
the Shared Savings Program,
distributions of shared savings by an
ACO, including downstream
arrangements, that incentivize the
provision of alternate and appropriate
medically necessary care consistent
with the purposes of the Shared Savings
Program (such as the provision of
coordinated outpatient care rather than
inpatient services or the use of
evidence-based protocols for medically
necessary care) are protected by this
waiver. Knowing payments by a
hospital to induce a physician to reduce
or limit medically necessary care
without providing acceptable alternative
medically necessary care (for example,
payments to discharge patients without
regard to appropriate care transitions or
payments to use a drug or device known
to be clinically less effective) would not
qualify for the waiver. We will interpret
‘‘medical necessity’’ consistent with
Medicare program rules and accepted
standards of practice. We also note that
distributions of shared savings
payments also may be structured to fit
in the other waivers.
Finally, we have not included in this
IFC specific waiver protection for the
distribution of shared savings earned by
an ACO enrolled in the Shared Savings
Program under a comparable program
sponsored by a commercial health plan.
We recognize that ACOs participating in
the Shared Savings Program may also
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
receive similar performance-based
payments from commercial plans and
that those payments may reflect care
coordination, quality improvement, and
cost-effectiveness activities similar to
those promoted by the Shared Savings
Program. However, at this time, we are
not persuaded that a specific waiver for
such payments is necessary to carry out
the Shared Savings Program. In
addition, we lack an adequate basis for
identifying comparable private payer
arrangements of ACOs that would be
subject to the waiver.
Shared savings or similar
performance-based payments received
from a commercial plan do not
necessarily implicate the fraud and
abuse laws; however, in some
circumstances, funds are calculated or
used in downstream arrangements in
ways that influence the referring of, or
ordering for, Medicare or other Federal
health care program patients. Moreover,
we are mindful of the concerns
expressed by commenters that some
private payer arrangements may be
sensitive to the volume of business
generated for downstream providers or
suppliers and that this characteristic
may have implications for the
application of the Physician SelfReferral Law.
Although we are not providing a
specific waiver for private payer
arrangements at this time, we believe
avenues exist to provide flexibility for
ACOs participating in commercial
plans. First, nothing precludes
arrangements ‘‘downstream’’ of
commercial plans (for example,
arrangements between hospitals and
physician groups) from qualifying for
the participation waiver described in
section IV. of this IFC. The participation
waiver does not turn on the source of
the funds for the arrangement. Second,
many commercial shared savings
arrangements are, or can be, structured
to fit within the Physician Self-Referral
Law exception for risk-sharing
arrangements at 42 CFR 411.357(n) and
some may be structured to fit in other
exceptions. Some private payer
arrangements may also fit in existing
Federal anti-kickback statute safe
harbors, such as the managed care safe
harbors. Finally, as noted previously in
this IFC, no waiver or other protection
is needed for private payer
arrangements that do not implicate the
fraud and abuse laws.
We are soliciting comments on our
approach to shared savings
arrangements with commercial plans,
whether our approach is consistent with
the needs of ACOs participating in the
Shared Savings Program, and whether a
specific waiver should apply to shared
PO 00000
Frm 00016
Fmt 4701
Sfmt 4700
savings derived from commercial plans
comparable to the Shared Savings
Program (and, if so, how we should
define a comparable program with
sufficient precision).
E. Compliance With the Physician SelfReferral Law Waiver
This waiver is intended to ease the
compliance burden on providers that
might elect to use existing Physician
Self-Referral Law exceptions for their
ACO arrangements and to reassure those
with existing arrangements that already
fit in such an exception that they need
not undertake a separate legal review
under the Federal anti-kickback statute
or Gainsharing CMP. This waiver covers
arrangements that otherwise implicate
the Physician Self-Referral Law,
meaning, for example, arrangements
involving designated health services
entities, as defined at 42 CFR 411.351,
and referring physicians, as defined at
42 CFR 411.351. Arrangements that
cannot qualify for a Physician SelfReferral Law exception because they are
not within the ambit of the law, such as
arrangements between facilities that do
not involve referring physicians, can
qualify for the other waivers described
in this IFC. Ordinarily, compliance with
an exception to the Physician SelfReferral Law does not operate to
immunize conduct under the Federal
anti-kickback statute or Gainsharing
CMP, and arrangements that comply
with the Physician Self-Referral Law are
still subject to scrutiny under the
Federal anti-kickback statute and
Gainsharing CMP. Here, however, we
are deviating from this general rule in
view of the specific safeguards in the
Shared Savings Program, the authority
under section 1899(f) of the Act for the
Secretary to waive the Federal antikickback statute and Gainsharing CMP
as necessary to carry out the Shared
Savings Program, and our desire to
minimize burdens on entities
establishing or operating ACOs under
the Shared Savings Program.
This waiver is structured to apply
until the participation agreement,
including any renewals thereof, expires
or terminates. We are considering
whether it might be necessary for this
particular waiver to continue for some
period of time, perhaps in the range of
3 to 12 months, after expiration or
termination of an ACO’s participation
agreement. We are soliciting comments
on this consideration.
F. Waiver for Patient Incentives
As described in section III of this IFC,
several public commenters indicated
that, in carrying out the quality and cost
reduction goals of the Shared Savings
E:\FR\FM\02NOR3.SGM
02NOR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
Program, ACOs would need to engage
patients in better managing their own
health care, including obtaining
preventive care and complying with
treatment plans for chronic conditions.
Therefore, in light of this need, this IFC
promulgates a waiver of the Federal
anti-kickback statute and Beneficiary
Inducements CMP to address
arrangements pursuant to which ACOs,
ACO participants, and ACO providers/
suppliers provide beneficiaries with free
or below-fair market value items and
services that advance the goals of
preventive care, adherence to treatment,
drug, or follow-up care regimes, or
management of a chronic disease or
condition. This waiver will help ACOs
foster patient engagement in improving
quality and lowering costs for Medicare
and beneficiaries by removing any
perceived obstacles presented by the
Beneficiary Inducements CMP or
Federal anti-kickback statute.
Beneficiary compliance with care
management programs is critical to the
success of ACOs, and ACOs should have
the flexibility to develop incentives to
that end, with certain safeguards. In the
interest of promoting broad
improvement in care coordination and
quality for all beneficiaries and in light
of the mechanisms for assigning
beneficiaries under the Shared Savings
Program final rule, at this time we are
not limiting this waiver to beneficiaries
assigned to the ACO. However, we are
soliciting comments on whether the
waiver could and should be limited to
beneficiaries assigned to the ACO.
In order to balance the goal of
beneficiary compliance with care
management programs against the risk
that ACOs could use extravagant
incentives to steer beneficiaries, we are
requiring that there be a reasonable
connection between the incentives and
the medical care of the individual. By
way of example, the waiver would cover
blood pressure cuffs for hypertensive
patients, but not beauty products or
theatre tickets. The waiver will protect
incentives that are in-kind items or
services, but not financial incentives,
such as waiving or reducing patient cost
sharing amounts (that is, copayment or
deductible), which we believe are prone
to greater abuse. We note that the
Shared Savings Program at 42 CFR
425.304(a)(1) itself prohibits ACOs,
ACO participants, ACO providers/
suppliers, and other individuals or
entities performing functions or services
related to ACO activities from providing
gifts or other remuneration to
beneficiaries as inducements for
receiving items or services from, or
remaining in, an ACO or with providers
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
in a particular ACO or receiving items
or services from ACO participants or
ACO providers/suppliers; clearly then,
such incentives are not covered by this
waiver. As further provided in the
Shared Savings Program final rule,
42 CFR 425.304(a)(2) permits certain
incentives that are consistent with the
requirements of 42 CFR 425.304(a)(1)
and the terms of this waiver. This
waiver applies only to the application of
the Federal anti-kickback statute and
Gainsharing CMP; nothing in this
waiver supplants any applicable
requirement in the Shared Savings
Program final rule or other Medicare
payment or coverage rules. We are not
defining preventive care for purposes of
this waiver in order to provide some
flexibility as care models develop in the
Shared Savings Program and evidencebased care programs are adopted by
ACOs. However, we are soliciting
comments on whether we should
provide a specific definition.
This waiver does not protect the
provision of free or below fair market
value items or services by
manufacturers or other vendors to
beneficiaries, the ACO, ACO
participants, or ACO providers/
suppliers. The patient incentives waiver
would cover ACOs, ACO participants,
and ACO provider/suppliers that give
beneficiaries items or services that they
have received from manufacturers at
discounted rates. However, the waiver
would not cover the discount
arrangement (or any arrangement for
free items and services) between the
manufacturer and the ACO, ACO
participant, or ACO provider/supplier.
This waiver applies during the term of
the ACO’s participation agreement.
However, to ensure continuity of care
for beneficiaries if an ACO’s agreement
terminates or is not renewed, we are
providing that a beneficiary may keep
any items received during the term of
the ACO’s participation agreement
pursuant to the waiver and may
continue to receive any service initiated
during the term of the ACO’s
participation agreement pursuant to the
waiver, if the service was in progress
when the participation agreement
terminated. Illustrative examples could
include, but would not be limited to, a
post-surgical patient receiving free
home visits to coordinate in-home care
during the recovery period, a
hypertensive patient using home
telehealth monitoring of blood pressure,
or a beneficiary halfway through a
normal course of smoking cessation
treatment. Nothing precludes ACOs,
ACO participants, or ACO providers/
suppliers from offering patient
incentives to promote their clinical care
PO 00000
Frm 00017
Fmt 4701
Sfmt 4700
68007
if the incentives fit in an applicable safe
harbor or exception or do not otherwise
violate the Federal anti-kickback statute
and Beneficiary Inducements CMP. For
example, many such arrangements may
fit in the exception to the Beneficiary
Inducements CMP for incentives given
to individuals to promote the delivery of
preventive care at section 1128A(i)(6)(D)
of the Act; 42 CFR 1003.101.
G. Application of Waivers to Innovation
Center Demonstrations
Several commenters inquired about
the application of these waivers to ACO
demonstration programs sponsored by
the Innovation Center, including
application to the Pioneer ACOs. The
waivers in this IFC are promulgated
under section 1899(f) of the Act and, as
set forth in the statute, are limited to the
Shared Savings Program. Section 3021
of the Affordable Care Act includes a
similar waiver authority that may be
exercised for Innovation Center
demonstration programs, including the
Pioneer ACOs. We will address the
exercise of that waiver authority in
guidance relevant to those programs. As
noted previously in this IFC, the
waivers in this IFC will apply to ACOs
participating in the Advance Payment
Initiative because those ACOs also
participate in the Shared Savings
Program.
H. Additional Policy Considerations and
Solicitation of Comments
The waivers adopted in this IFC take
into account the specific redesigned
care delivery incentives and processes
of the Shared Savings Program, as well
as the obligation of ACOs, ACO
participants, and ACO providers/
suppliers to comply with the Shared
Savings Program rules, including
requirements addressing governance,
management, leadership, transparency,
data, quality, performance, compliance,
patient freedom of choice, and others.
Moreover, the Shared Savings Program
requires ACOs and their constituent
parts to demonstrate a meaningful
commitment to the Shared Savings
Program. The waivers emanate from the
expectation that ACOs and their
constituent parts will act in compliance
with program rules and in the best
interests of patients and the Medicare
program, including the Shared Savings
Program. The waivers are an attempt to
promote a high degree of certainty,
innovation, and variation in the
development of ACOs to improve
quality of care, as well as economy and
efficiency in the Medicare program.
The government’s enforcement
experience reflects that, to varying
degrees, all Federal health care
E:\FR\FM\02NOR3.SGM
02NOR3
mstockstill on DSK4VPTVN1PROD with RULES3
68008
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
programs are susceptible to fraud and
abuse. These waivers should not be read
to reflect any diminution of our
commitment to protect programs and
beneficiaries from harms associated
with kickbacks and referral payments,
including overutilization, increased
costs, and substandard or poor quality
care. DHHS will monitor ACOs and the
Shared Savings Program as a whole for
fraud or abuse, such as billing for
medically unnecessary or upcoded
services, submitting false or fraudulent
data, or providing worthless or
substandard care. If these or other
problematic practices are found, the
government has a number of tools to
address the problem. In appropriate
cases, we will use these tools to protect
the interests of beneficiaries and the
Medicare program.
We intend to closely monitor ACOs
entering the program in 2012 through
June 2013. We plan to narrow the
waivers established in this IFC unless
the Secretary determines that
information gathered through
monitoring or other means suggests that
such waivers have not had the
unintended effect of shielding abusive
arrangements.8 In particular, if we find
that undesirable effects (for example,
aberrant patterns of utilization) have
occurred because of the waivers, we will
revise this IFC to address those
problems by narrowing the waivers.
Modifications to the waivers would
apply to future ACO applicants beyond
July 2013 and to ACOs that renew their
participation agreements. There are
several options for modifying the
waivers to address problems that may
arise. Should we identify specific areas
of fraud and abuse resulting from
arrangements covered by the waivers,
we could modify the waivers to add or
substitute conditions tailored to address
specific abusive conduct. We could also
limit ACO arrangements involving
referral sources to those that are fair
market value or commercially
reasonable or involve services
performed by the referral source. This
approach could include exceptions for
specified arrangements, including, for
example, a limited amount of start-up
costs, information technology, medical
training, care coordination, or goods or
services provided to referral sources’
patients. In addition, we could preclude
waiver protection for arrangements that
involve individuals or entities that are
not part of the ACO or we could include
8 As described in section III of this IFC, several
commenters suggested that we establish either
narrow waivers or none at all; some commenters
suggested specific additional conditions for waivers
that we have not adopted,
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
a requirement that ACOs submit reports
to the Secretary regarding their
arrangements. We solicit comments in
this rulemaking regarding these narrow
waivers. We also seek comments on
additional categories of arrangements
that would require protection through a
waiver and how the categories should
be defined and what limits, if any,
should be imposed.
We are establishing waivers under
section 1899(f) of the Act to foster the
success of the Shared Savings Program,
the purposes of which are to promote
accountability for a Medicare patient
population, manage and coordinate care
for Medicare fee-for-service
beneficiaries, and encourage redesigned
care processes to improve quality. Our
goal is to balance effectively the need
for ACO certainty, innovation, and
flexibility in the Shared Savings
Program with protections for
beneficiaries and the Medicare program.
It is our expectation that the waivers
promulgated in this IFC will be used for
their intended purposes to carry out the
Shared Savings Program. We will
closely monitor the program and ACO
conduct. We plan to narrow the waivers
in this IFC unless information gathered
through monitoring or other means
suggests that the waivers in this IFC are
adequately protecting the Medicare
program and beneficiaries from the
types of harms associated with referral
payments or payments to reduce or limit
services. We are soliciting comment on
the specific narrowed waivers described
above.
VI. Procedural Rulemaking Matters
A. Waiver of Proposed Rulemaking
Under the Administrative Procedures
Act (5 U.S.C. 553(b)), an agency may
waive publication of a notice of
proposed rulemaking if the agency finds
good cause that the notice and comment
procedure is impracticable,
unnecessary, or contrary to the public
interest and the agency incorporates
into the rule a statement of, and the
reasons for, such a finding. For the
reasons discussed later in this IFC, we
find that it would be unnecessary,
impracticable, and contrary to the
public interest to delay the issuance of
the waivers granted in this IFC until
after a public notice and comment
process is completed.
In section 1899(a)(1) of the Act,
Congress expressly required the
Secretary to establish the Shared
Savings Program no later than January 1,
2012. As noted earlier in this document,
Congress authorized the Secretary to
waive the requirements of sections
1128A and 1128B and title XVIII of the
PO 00000
Frm 00018
Fmt 4701
Sfmt 4700
Act as may be necessary to carry out the
Shared Savings Program. The Physician
Self-Referral Law, the Federal antikickback statute, the Gainsharing CMP,
and the Beneficiary Inducements CMP,
discussed elsewhere in this IFC, are
important tools to protect patients and
the Federal health care programs from
fraud, improper referral payments,
unnecessary utilization,
underutilization, and other harms.
We recognize, however, that these
laws may prohibit or significantly
restrict certain arrangements necessary
for the formation of ACOs under the
Shared Savings Program. Moreover, the
significant financial consequences of
noncompliance with these laws (and the
potential False Claims Act liability) will
likely have a chilling effect on the
willingness of health care providers to
participate in the Shared Savings
Program at its inception if these
provisions are not waived. Delaying the
issuance of final waivers would
effectively delay the program’s
establishment well beyond the statutory
deadline and delay the savings that the
program is expected to achieve at a time
when reducing the Federal budget is a
critical priority. For this reason, it is
impracticable and contrary to the public
interest to issue the waivers of these
laws only after additional months of
notice and comment rulemaking. In
addition, the failure to simultaneously
issue the Shared Savings Program final
rule and the waivers promulgated in
this IFC would impede development of
the innovative integrated-care models
envisioned by the Shared Savings
Program and deny Medicare
beneficiaries the opportunity to benefit
from a new approach to the delivery of
health care that is designed to result in
better care for individuals, and better
health for populations, as well as lower
growth in expenditures. Neither result is
in the public interest.
We also believe it is unnecessary to
offer what would essentially be a second
opportunity to comment on these
waivers and thereby delay finalizing
waivers that will permit arrangements
that are essential to the implementation
success of the Shared Savings Program.
On April 7, 2011, we published the
Waiver Designs Notice. That notice
solicited public comment regarding
possible waivers of the application of
the Physician Self-Referral Law, the
Federal anti-kickback statute, and
certain civil monetary penalties law
provisions to specified arrangements
involving ACOs under the Shared
Savings Program. This IFC responds to
public comments received on that
notice. Moreover, the public will
nonetheless receive an opportunity to
E:\FR\FM\02NOR3.SGM
02NOR3
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES3
comment on the specific policy choices
made in this rule because we are
publishing it as an IFC. In accordance
with section 1871(a)(3) of the Act, we
are obligated to consider comments and
publish a final rule addressing those
comments within 3 years.
Finally, we note that in the absence of
final program rules, it would have been
impracticable, if not impossible, to issue
a comprehensive notice of proposed
rulemaking on fraud and abuse waivers
that would adequately support the
Shared Savings Program. As we stated
in the Waiver Designs Notice, the
requirements of the final program rules
regarding the structure and operations
of ACOs under the Shared Savings
Program would affect the scope of the
waivers. For this reason, we indicated in
the Waiver Designs Notice that, in
drafting the final waivers, we would
consider comments received on the
Shared Savings Program proposed rule
and the terms of the final rule. We have,
in fact, done so in creating the waivers
set forth in this IFC. Simply put, the
proposal of definitive waivers was not
possible until now.
For the reasons noted previously in
this IFC, we believe that it would be
impracticable and contrary to the public
interest to delay the issuance of final
waivers until after the receipt and
analysis of additional public comments.
Therefore, we find good cause to waive
prior notice and comment procedure
and to issue this final rule on an interim
basis. We are providing a 60-day public
comment period.
B. Waiver of Delayed Effective Date
Section 1871(e)(1) of the Act generally
requires that a final rule become
effective at least 30 days after the
issuance or publication of the rule. This
requirement for a 30-day delayed
effective date can be waived, however,
if the Secretary finds that waiver of the
30-day period is necessary to comply
with statutory requirements or that the
requirement for a delayed effective date
is contrary to the public interest.
As indicated previously in this IFC,
section 1899 of the Act expressly
requires the Secretary to establish the
Shared Savings Program no later than
January 1, 2012. Prospective ACOs that
wish to participate in the Medicare
Shared Savings Program in 2012 must
submit an application and enter into a
participation agreement with CMS that
commences on April 1, 2012 or July 1,
2012. We expect that the application
deadline for participation agreements
with an April 1, 2012 start date will be
no later than January 1, 2012. Based on
the comments submitted in response to
the Waiver Designs Notice, we believe
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
that a significant number of ACO
applicants for the Shared Savings
Program would forego applying to
participate in the Shared Savings
Program until final waivers have
become effective and sufficient time has
elapsed to allow the applicants to use
the waivers in a manner that would
support their applications and the
purposes of the program. We believe
that a 30-day delay in the effective date
for the final waivers could jeopardize an
ACO’s ability to submit timely an
application for a participation
agreement commencing in 2012. For
this reason, we find that waiver of the
requirement for a delayed effective date
is necessary to comply with a statutory
requirement.
We also find that a delayed effective
date would be contrary to the public
interest. The success of the Shared
Savings Program depends in no small
part on allowing prospective ACOs
sufficient time to prepare for application
to the program and to build the
innovative, cost effective, integrated
healthcare delivery models envisioned
by the Shared Savings Program.
Delaying the effective date of this rule
would be contrary to the public interest
because it would effectively delay the
timely implementation of the Shared
Savings Program, thereby denying the
public the benefits of a new approach to
health care delivery that is designed to
result in better care for individuals, and
better health for populations, as well as
lower growth in expenditures.
In addition, we find that it is not in
the public interest to delay the effective
date of a rule that does not impose a
burden upon anyone. This IFC waives
the aforementioned authorities,
provided certain conditions are met. In
short, the rule rescinds, rather than
adds, restrictions with which
prospective ACOs, their prospective
ACO participants, and their prospective
ACO providers/suppliers must comply.
Accordingly, a delay in the effective
date of this IFC is unnecessary and
contrary to the public interest.
VII. Collection of Information
Requirements
While this IFC does include
information collection and record
keeping requirements, section 3022 of
the Affordable Care Act provides that
Chapter 35 of title 44, United States
Code, shall not apply to the Shared
Savings Program. Consequently, the
information collection requirements
contained in this IFC need not be
reviewed by the Office of Management
and Budget.
PO 00000
Frm 00019
Fmt 4701
Sfmt 4700
68009
VIII. Regulatory Impact Statement
We have examined the impact of this
rule as required by Executive Order
12866 on Regulatory Planning and
Review (September 30, 1993), Executive
Order 13563 on Improving Regulation
and Regulatory Review (February 2,
2011), the Regulatory Flexibility Act
(RFA) (September 19, 1980, Pub. L. 96–
354), section 1102(b) of the Social
Security Act, section 202 of the
Unfunded Mandates Reform Act of 1995
(March 22, 1995; Pub. L. 104–4),
Executive Order 13132 on Federalism
(August 4, 1999) and the Congressional
Review Act (5 U.S.C. 804(2)).
Executive Orders 12866 and 13563
direct agencies to assess all costs and
benefits of available regulatory
alternatives and, if regulation is
necessary, to select regulatory
approaches that maximize net benefits
(including potential economic,
environmental, public health and safety
effects, distributive impacts, and
equity). A regulatory impact analysis
(RIA) must be prepared for major rules
with economically significant effects
($100 million or more in any 1 year).
This rule does not reach the economic
threshold and thus is not considered a
major rule.
The RFA requires agencies to analyze
options for regulatory relief of small
entities. For purposes of the RFA, small
entities include small businesses,
nonprofit organizations, and small
governmental jurisdictions. Most
hospitals and most other providers and
suppliers are small entities, either by
nonprofit status or by having revenues
of $7.0 million to $34.5 million in any
1 year. Individuals and States are not
included in the definition of a small
entity. We are not preparing an analysis
for the RFA because we have
determined, and the Secretary certifies,
that this IFC will not have a significant
economic impact on a substantial
number of small entities.
In addition, section 1102(b) of the Act
requires us to prepare a regulatory
impact analysis if a rule may have a
significant impact on the operations of
a substantial number of small rural
hospitals. This analysis must conform to
the provisions of section 604 of the
RFA. For purposes of section 1102(b) of
the Act, we define a small rural hospital
as a hospital that is located outside of
a Metropolitan Statistical Area for
Medicare payment regulations and has
fewer than 100 beds. We are not
preparing an analysis for section 1102(b)
of the Act because we have determined,
and the Secretary certifies, that this IFC
will not have a significant impact on the
E:\FR\FM\02NOR3.SGM
02NOR3
68010
Federal Register / Vol. 76, No. 212 / Wednesday, November 2, 2011 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES3
operations of a substantial number of
small rural hospitals.
Section 202 of the Unfunded
Mandates Reform Act of 1995 also
requires that agencies assess anticipated
costs and benefits before issuing any
rule whose mandates require spending
in any 1 year of $100 million in 1995
dollars, updated annually for inflation.
In 2011, that threshold is approximately
$136 million. This rule will have no
consequential effect on State, local, or
tribal governments or on the private
sector.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a
proposed rule (and subsequent final
VerDate Mar<15>2010
18:12 Nov 01, 2011
Jkt 226001
rule) that imposes substantial direct
requirement costs on State and local
governments, preempts State law, or
otherwise has Federalism implications.
Since this regulation does not impose
any costs on State or local governments,
the requirements of Executive Order
13132 are not applicable.
In accordance with the provisions of
Executive Order 12866, this regulation
was reviewed by the Office of
Management and Budget.
For the reasons set forth in this
preamble, the Centers for Medicare &
Medicaid Services and the Office of the
Inspector General are implementing this
interim final rule under the authority of
section 1899 of the Act.
PO 00000
Frm 00020
Fmt 4701
Sfmt 9990
Authority: Section 1899(f) of the Act.
Dated: October 6, 2011.
Donald M. Berwick,
Administrator, Centers for Medicare &
Medicaid Services.
Dated: October 19, 2011.
Daniel R. Levinson,
Inspector General, Department of Health and
Human Services.
Approved: October 19, 2011.
Kathleen Sebelius,
Secretary, Department of Health and Human
Services.
[FR Doc. 2011–27460 Filed 10–20–11; 11:15 am]
BILLING CODE 4120–01–P; 4152–01–P
E:\FR\FM\02NOR3.SGM
02NOR3
Agencies
[Federal Register Volume 76, Number 212 (Wednesday, November 2, 2011)]
[Rules and Regulations]
[Pages 67992-68010]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27460]
[[Page 67991]]
Vol. 76
Wednesday,
No. 212
November 2, 2011
Part III
Department of Health and Human Services
-----------------------------------------------------------------------
Centers for Medicare & Medicaid Services
-----------------------------------------------------------------------
42 CFR Chapter IV
Office of the Inspector General
-----------------------------------------------------------------------
42 CFR Chapter V
Medicare Program; Final Waivers in Connection With the Shared Savings
Program; Interim Final Rule
Federal Register / Vol. 76 , No. 212 / Wednesday, November 2, 2011 /
Rules and Regulations
[[Page 67992]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Chapter IV
Office of Inspector General
42 CFR Chapter V
[CMS-1439-IFC]
RIN 0938-AR30
Medicare Program; Final Waivers in Connection With the Shared
Savings Program
AGENCY: Centers for Medicare & Medicaid Services (CMS) and Office of
Inspector General (OIG), HHS.
ACTION: Interim final rule with comment period.
-----------------------------------------------------------------------
SUMMARY: This interim final rule with comment period establishes
waivers of the application of the Physician Self-Referral Law, the
Federal anti-kickback statute, and certain civil monetary penalties
(CMP) law provisions to specified arrangements involving accountable
care organizations (ACOs) under section 1899 of the Social Security Act
(the Act) (the Shared Savings Program), including ACOs participating in
the Advance Payment Initiative. Section 1899(f) of the Act, as added by
the Affordable Care Act, authorizes the Secretary to waive certain
fraud and abuse laws as necessary to carry out the provisions of
section 1899 of the Act.
DATES: Effective date: These regulations are effective on November 2,
2011.
Comment date: To be assured consideration, comments must be
received at one of the addresses provided below, no later than 5 p.m.
on January 3, 2012. Because of the large number of public comments we
normally receive on Federal Register documents, we are not able to
acknowledge or respond to them individually. We will consider all
comments we receive by the date and time specified here, and, when we
proceed with a subsequent document, we will respond to the comments in
the preamble to that document.
ADDRESSES: In commenting, please refer to file code CMS-1439-IFC.
Because of staff and resource limitations, we cannot accept comments by
facsimile (FAX) transmission.
You may submit comments in one of four ways (please choose only one
of the ways listed)
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the ``Submit a
comment'' instructions.
2. By regular mail. You may mail written comments to the following
address only: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-1439-IFC, P.O. Box 8013,
Baltimore, MD 21244-8013.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address only: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-1439-IFC, Mail
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1813.
4. By hand or courier. Alternatively, you may deliver (by hand or
courier) your written comments only to the following addresses prior to
the close of the comment period:
a. For delivery in Washington, DC--Centers for Medicare & Medicaid
Services, Department of Health and Human Services, Room 445-G, Hubert
H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC
20201.
(Because access to the interior of the Hubert H. Humphrey Building
is not readily available to persons without Federal government
identification, commenters are encouraged to leave their comments in
the CMS drop slots located in the main lobby of the building. A stamp-
in clock is available for persons wishing to retain a proof of filing
by stamping in and retaining an extra copy of the comments being
filed.)
b. For delivery in Baltimore, MD--Centers for Medicare & Medicaid
Services, Department of Health and Human Services, 7500 Security
Boulevard, Baltimore, MD 21244-1850.
If you intend to deliver your comments to the Baltimore address,
call telephone number (410) 786-1066 in advance to schedule your
arrival with one of our staff members.
Comments erroneously mailed to the addresses indicated as
appropriate for hand or courier delivery may be delayed and received
after the comment period.
For information on viewing public comments, see the beginning of
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Neal Shah (410) 786-1167 or Kristin Bohl (410) 786-8680, for general
issues and issues related to the Physician Self-Referral Law.
James A. Cannatti III (202) 619-0335, for general issues and issues
related to the Federal anti-kickback statute or civil monetary
penalties.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. We post all comments
received before the close of the comment period on the following Web
site as soon as possible after they have been received: https://www.regulations.gov. Follow the search instructions on that Web site to
view public comments.
Comments received timely will be also available for public
inspection as they are received, generally beginning approximately 3
weeks after publication of a document, at the headquarters of the
Centers for Medicare & Medicaid Services, 7500 Security Boulevard,
Baltimore, Maryland 21244, Monday through Friday of each week from 8:30
a.m. to 4 p.m. To schedule an appointment to view public comments,
phone 1-800-743-3951.
I. Introduction and Overview
Section I. of this interim final rule with comment period (IFC)
provides an introduction and overview of this rule. Section II. of this
IFC provides background on the Shared Savings Program. Section III. of
this IFC summarizes public comments received in response to the Waiver
Designs Notice and Shared Savings Program proposed rule (as those terms
are defined below). Section IV. of this IFC sets out the waivers and
applicable requirements. Section V. of this IFC explains the waivers
and solicits comments on specific ways we might modify the waivers to
address fraud and abuse or other problems that may arise.
A. Connection Between Shared Savings Program and Fraud and Abuse
Waivers
Elsewhere in this issue of the Federal Register, the Centers for
Medicare & Medicaid Services (CMS) published a final rulemaking setting
forth the requirements for ACOs under the Shared Savings Program
(hereinafter referred to as the ``Shared Savings Program final rule'').
Section 1899 of the Act (as added by section 3022 of the Patient
Protection and Affordable Care Act (Pub. L. 111-148), as amended by the
Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
(collectively, the ``Affordable Care Act'') describes the Shared
Savings Program as a Medicare program to promote accountability for a
Medicare patient population, coordinate items
[[Page 67993]]
and services under Parts A and B, and encourage investment in
infrastructure and redesigned care processes for high quality and
efficient service delivery. As described in the Shared Savings Program
final rule, the Shared Savings Program is designed to achieve three
goals: Better health for populations, better care for individuals, and
lower growth in expenditures. CMS's expectation is that Shared Savings
Program accountable care organizations (ACO) \1\ will help foster a new
approach to delivering care that reduces fragmented or unnecessary care
and excessive costs for Medicare fee-for-service beneficiaries and
other patients.
---------------------------------------------------------------------------
\1\ For purposes of this IFC, the terms ``ACO,'' ``ACO
participants,'' and ``ACO providers/suppliers'' have the meanings
ascribed to them in 42 CFR 425.20.
---------------------------------------------------------------------------
The Physician Self-Referral Law, the Federal anti-kickback statute,
and the civil monetary penalties (CMP) law provisions addressing
inducements to beneficiaries and hospital payments to physicians to
reduce or limit services, described in greater detail elsewhere in this
IFC, are some of the important tools used to protect patients and the
Federal health care programs from fraud, improper referral payments,
unnecessary utilization, underutilization, and other harms. However,
stakeholders have expressed concern that the restrictions these laws
place on certain arrangements between physicians, hospitals, and other
individuals and entities may impede development of some of the
innovative integrated-care models envisioned by the Shared Savings
Program. Section 1899(f) of the Act authorizes the Secretary to waive
these and certain other laws as necessary to carry out the Shared
Savings Program. Based on stakeholder input and other factors, the
Secretary has found that it is necessary to waive these fraud and abuse
laws in order to carry out the Shared Savings Program.
Accordingly, this IFC sets forth waivers of certain provisions of
the Physician Self-Referral Law, the Federal anti-kickback statute, the
CMP law prohibiting hospital payments to physicians to reduce or limit
services (the Gainsharing CMP), and the CMP law prohibiting inducements
to beneficiaries (the Beneficiary Inducements CMP) as necessary to
carry out the provisions of section 1899 of the Act. We seek to waive
application of these fraud and abuse laws to ACOs formed in connection
with the Shared Savings Program so that the laws do not unduly impede
development of beneficial ACOs, while also ensuring that ACO
arrangements are not misused for fraudulent or abusive purposes that
harm patients or Federal health care programs.
The waivers set forth in this IFC are promulgated pursuant to the
specific authority at section 1899(f) of the Act. This authority
applies only to the Shared Savings Program and to all ACOs
participating in the Shared Savings Program. This includes those Shared
Savings Program ACOs that are also participating in the Advance Payment
Initiative to be administered by the Center for Medicare & Medicaid
Innovation (Innovation Center). The Affordable Care Act includes
separate authority for the Secretary to waive fraud and abuse laws for
certain other demonstrations and pilot programs. Guidance regarding
such waivers will be issued separately.
B. Overview of Final Waivers
On April 7, 2011, CMS and OIG jointly published a notice with
comment period seeking public comment on certain proposed waivers and
other waiver design considerations (Waiver Designs in Connection with
the Shared Savings Program and the Innovation Center (76 FR 19655))
(hereinafter referred to as the ``Waiver Designs Notice''). In that
same issue of the Federal Register, CMS published a proposed rulemaking
setting forth proposed requirements for ACOs under the Shared Savings
Program (Shared Savings Program: Accountable Care Organizations (76 FR
19528)) (hereinafter referred to as the ``Shared Savings Program
proposed rule'') and soliciting public comments.
CMS and OIG are jointly establishing waivers under this IFC to
provide stakeholders with a coordinated approach to the waivers of
fraud and abuse laws in connection with the Shared Savings Program.
Administration of the Physician Self-Referral Law is the responsibility
of CMS; the OIG is responsible for enforcement of the CMP provisions
under the Physician Self-Referral Law. OIG shares responsibility for
the Federal anti-kickback statute with the Department of Justice. The
Gainsharing CMP and Beneficiary Inducements CMP are administered by the
OIG.
For reasons elaborated in more detail elsewhere in this IFC, the
Secretary has determined, based on consideration of public input and
the Department's own analysis, that it is necessary to waive certain
provisions of the Physician Self-Referral Law, the Federal anti-
kickback statute, the Gainsharing CMP, and the Beneficiary Inducements
CMP in some circumstances to carry out the Shared Savings Program.
Section IV. of this IFC sets out the specific waivers and the
conditions pertaining to them. Section V. of this IFC provides
commentary explaining the waivers and solicits comments on possible
modifications. There are five waivers addressing different
circumstances--
An ``ACO pre-participation'' waiver of the Physician Self-
Referral Law, the Federal anti-kickback statute, and the Gainsharing
CMP that applies to ACO-related start-up arrangements in anticipation
of participating in the Shared Savings Program, subject to certain
limitations, including limits on the duration of the waiver and the
types of parties covered;
An ``ACO participation'' waiver of the Physician Self-
Referral Law, the Federal anti-kickback statute, and the Gainsharing
CMP that applies broadly to ACO-related arrangements during the term of
the ACO's participation agreement under the Shared Savings Program and
for a specified time thereafter;
A ``shared savings distributions'' waiver of the Physician
Self-Referral Law, Federal anti-kickback statute, and Gainsharing CMP
that applies to distributions and uses of shared savings payments
earned under the Shared Savings Program;
A ``compliance with the Physician Self-Referral Law''
waiver of the Gainsharing CMP and the Federal anti-kickback statute for
ACO arrangements that implicate the Physician Self-Referral Law and
meet an existing exception; and
A ``patient incentive'' waiver of the Beneficiary
Inducements CMP and the Federal anti-kickback statute for medically
related incentives offered by ACOs under the Shared Savings Program to
beneficiaries to encourage preventive care and compliance with
treatment regimes.
These waivers include the two waivers proposed in the Waiver
Designs Notice (the shared savings distributions waiver and the
compliance with the Physician Self-Referral Law waiver), as well as
three new waivers developed in response to public comments seeking
additional pathways to address a broader array of ACO activities needed
to achieve the purposes of the Shared Savings Program. These five
waivers provide flexibility for ACOs and their constituent parts to
pursue a wide array of activities, including start-up and operating
activities that further the purposes of the Shared Savings Program.
These waivers incorporate conditions that, in combination with
[[Page 67994]]
additional safeguards in the Shared Savings Program final rule, are
intended to protect Medicare beneficiaries and the Medicare program
from fraud and abuse while furthering the quality, economy, and
efficiency goals of the Shared Savings Program.
An arrangement need only fit in one waiver to be protected; parties
seeking to ensure that an arrangement is covered by a waiver for a
particular law may look to any waiver that applies to that law. In some
cases, an arrangement may meet the criteria of more than one waiver.
II. Shared Savings Program: Background
A. Section 1899 of the Social Security Act
Section 1899 of the Act establishes the Shared Savings Program to
encourage the development of ACOs in Medicare. The Shared Savings
Program is one of the first initiatives implemented under the
Affordable Care Act aimed specifically at improving ``value'' in the
Medicare program--that is, both higher quality and lower total
expenditures for individual Medicare beneficiaries and the Medicare
program. Section 1899 of the Act encourages ACOs to promote
accountability for individual Medicare beneficiaries and population
health management, improve the coordination of patient care under Parts
A and B, and encourage investment in infrastructure and redesigned care
processes for high quality and efficient service delivery. Redesigned
care processes may improve care, increase efficiency, and lower costs
for Medicare and other patients served by the ACO.
In accordance with the Shared Savings Program final rule, ACOs will
enter into a participation agreement with the Secretary to participate
in the Shared Savings Program for no less than a 3-year period under
one of two tracks. Under the first track, an ACO will have the
opportunity to share in savings generated during the agreement. Under
the second track, ACOs will operate under a ``two-sided risk'' model in
which they will be eligible to receive a higher share of savings, but
will also be required to repay a portion of the losses sustained by the
Medicare program if costs for the ACO's assigned beneficiaries exceed
certain thresholds. Under either model, in order to share a percentage
of achieved savings with the Medicare program, ACOs must successfully
meet quality and savings requirements and certain other conditions
under the Shared Savings Program. ACO participants and ACO providers/
suppliers will continue to receive fee-for-service payments, and, under
the Shared Savings Program, the ACO legal entity may choose how it
distributes shared savings or allocates risk among its ACO participants
and its ACO providers/suppliers. ACOs in the Shared Savings Program
must also comply with requirements addressing governance, management,
and leadership of the ACO, as well as program integrity, transparency,
compliance plan, and certification requirements, among others.
B. Waiver Authority Under Section 1899(f) of the Act
Section 1899(f) of the Act provides that ``[t]he Secretary may
waive such requirements of sections 1128A and 1128B and title XVIII of
[the] Act as may be necessary to carry out the provisions of [section
1899 of the Act].'' This waiver authority is specific to the Shared
Savings Program, and does not apply to other similar integrated-care
delivery models. We may consider waivers (where authorized under the
Affordable Care Act), exceptions, or safe harbors, as applicable, for
other types of accountable care organizations, integrated-care delivery
models, or arrangements at a later date. As explained in section V. of
this IFC, any waivers for Innovation Center demonstration programs,
apart from the Advance Payment Initiative, will be issued separately
under the relevant authority.
We note that a waiver of a specific fraud and abuse law is not
needed for an arrangement to the extent that the arrangement: (1) Does
not implicate the specific fraud and abuse law; or (2) implicates the
law, but either fits within an existing exception or safe harbor, as
applicable, or does not otherwise violate the law. Arrangements that do
not fit in a waiver have no special protection and must be evaluated on
a case-by-case basis for compliance with the Physician Self-Referral
Law, the Federal anti-kickback statute, and the CMP laws. Failure to
fit in a waiver is not, in and of itself, a violation of the laws.
Existing exceptions and safe harbors might apply to ACO arrangements,
depending on the circumstances.\2\ These include, among others,
Physician Self-Referral Law exceptions for employment, personal
services arrangements, in-office ancillary services, electronic health
records (EHR) arrangements, risk-sharing, and indirect compensation
arrangements (to the extent an ACO arrangement is an indirect financial
relationship). Potential Federal anti-kickback statute safe harbors
include, among others, those for employment, personal services and
management contracts, EHR arrangements, and managed care arrangements.
---------------------------------------------------------------------------
\2\ 42 CFR 411.355 through 411.357; 42 CFR 1001.952; 42 CFR
1003.110.
---------------------------------------------------------------------------
The waiver authority under section 1899(f) is limited to sections
1128A and 1128B and title XVIII of the Act, and does not extend to any
other laws or regulations, including, without limitation, the Internal
Revenue Code (IRC) or State laws and regulations. Accordingly, nothing
in this IFC affects the obligations of individuals or entities,
including tax-exempt organizations, to comply with the IRC or other
Federal or State laws and regulations. Moreover, nothing in this IFC
changes any Medicare program reimbursement or coverage rule or alters
any obligations parties may have under the Shared Savings Program.
Although the waivers described in this IFC are necessary to ensure that
the fraud and abuse laws do not unduly impede development of ACOs in
connection with the Shared Savings Program, the waivers are not
intended to suggest that any particular arrangement between particular
parties is necessary to implementing the Shared Savings Program.
C. Fraud and Abuse Laws--Background
1. Physician Self-Referral Law (Section 1877 of the Act)
Section 1877 of the Act (42 U.S.C. 1395nn, the ``Physician Self-
Referral Law'') is a civil statute that prohibits physicians from
making referrals for Medicare ``designated health services,'' including
hospital services, to entities with which they or their immediate
family members have a financial relationship, unless an exception
applies. These entities may not bill Medicare for services rendered as
a result of a prohibited referral, and section 1877(g)(1) of the Act
states that no payment may be made for a designated health service that
is furnished pursuant to a prohibited referral. CMPs also apply to any
person who presents (or causes to be presented) a bill for services for
which he or she knows or should know payment may not be made under
section 1877(g)(1) of the Act. For additional details, see section
1877(g)(3) of the Act. Violations of the Physician Self-Referral Law
may also result in liability under the False Claims Act (31 U.S.C.
3729-33).
2. The Federal Anti-Kickback Statute (Section 1128B(b) of the Act)
Section 1128B(b) of the Act (42 U.S.C. 1320a-7b(b), the ``Federal
anti-kickback statute'') provides criminal penalties for
[[Page 67995]]
individuals or entities that knowingly and willfully offer, pay,
solicit, or receive remuneration to induce or reward the referral of
business reimbursable under any of the Federal health care programs, as
defined in section 1128B(f) of the Act. The offense is classified as a
felony and is punishable by fines of up to $25,000 and imprisonment for
up to 5 years. Violations of the Federal anti-kickback statute may also
result in the imposition of CMPs under section 1128A(a)(7) of the Act
(42 U.S.C. 1320a-7a(a)(7)), program exclusion under section 1128(b)(7)
of the Act (42 U.S.C. 1320a-7(b)(7)), and liability under the False
Claims Act (31 U.S.C. 3729-33). Certain practices that meet all of the
conditions of a safe harbor at 42 CFR 1001.952 are not subject to
prosecution or sanctions under the Federal anti-kickback statute.
3. Prohibition on Inducements to Beneficiaries (Section 1128A(a)(5) of
the Act)
Section 1128A(a)(5) of the Act (42 U.S.C. 1320a-7a(a)(5)), the
``Beneficiary Inducements CMP'') prohibits individuals and entities
from offering or transferring remuneration to Medicare or Medicaid
beneficiaries that the individual or entity knows or should know is
likely to influence the beneficiary to order or receive from a
particular provider, practitioner, or supplier any Medicare or Medicaid
item or service. There are existing exceptions to the Beneficiary
Inducements CMP at section 1128A(i)(6) of the Act.
4. Prohibition on Hospital Payments to Physicians To Induce Reduction
or Limitation of Services (Sections 1128A(b)(1) and (2) of the Act)
Sections 1128A(b)(1) and (2) of the Act (42 U.S.C. 1320a-7a(b)(1)
and (2), the ``Gainsharing CMP'') apply to certain payment arrangements
between hospitals and physicians, including arrangements commonly
referred to as ``gainsharing'' arrangements. Under section 1128A(b)(1)
of the Act, a hospital is prohibited from making a payment, directly or
indirectly, to induce a physician to reduce or limit services to
Medicare or Medicaid beneficiaries under the physician's direct care.
Hospitals that make (and physicians who receive) such payments are
liable for CMPs of up to $2,000 per patient covered by the payments
(sections 1128A(b)(1) and (2) of the Act).
D. Summary of Public Input Opportunities
Since passage of the Affordable Care Act, the U.S. Department of
Health and Human Services (DHHS) has offered numerous opportunities for
the public to provide input into the design and operation of ACOs and
waivers necessary to carry out the provisions of the Shared Savings
Program, most recently through the Waiver Designs Notice described
previously in this IFC. In addition, CMS issued a Request for
Information Regarding Accountable Care Organizations and the Shared
Saving Program on November 10, 2010,\3\ and held multiple listening
sessions with stakeholders. CMS, OIG, and the Federal Trade Commission
held a joint workshop on October 5, 2010, entitled ``Workshop Regarding
Accountable Care Organizations, and Implications Regarding Antitrust,
Physician Self-Referral, Anti-Kickback, and Civil Monetary Penalty
(CMP) Laws.'' \4\ We also received and reviewed written public comments
in connection with the workshop.\5\ Finally, we received public
comments related to the waivers in response to the Waiver Designs
Notice and the Shared Savings Program proposed rule. Through these
means, DHHS has received public input representing a wide spectrum of
views.
---------------------------------------------------------------------------
\3\ 75 FR 70165 (2010).
\4\ Information about the workshop is available on CMS's Web
site at https://www.cms.gov/center/physician.asp.
\5\ The public comments are available on the FTC's Web site at
https://www.ftc.gov/os/comments/aco/index.shtm.
---------------------------------------------------------------------------
E. Contents of Waiver Designs Notice
The Waiver Designs Notice proposed several waivers related to ACOs
in the Shared Savings Program and also solicited public comments on a
range of issues. The proposed waivers included waivers of certain
provisions of the Physician Self-Referral Law and the Federal anti-
kickback statute to distributions of shared savings received by an ACO
from CMS under the Medicare Shared Savings Program: (1) To or among ACO
participants, ACO providers/suppliers, and individuals and entities
that were ACO participants or ACO providers/suppliers during the year
in which the shared savings were earned by the ACO; or (2) for
activities necessary for and directly related to the ACO's
participation in and operations under the Shared Savings Program. We
also proposed to waive certain provisions of the Federal anti-kickback
statute with respect to any financial relationship between or among the
ACO, ACO participants, and ACO providers/suppliers necessary for and
directly related to the ACO's participation in and operations under the
Medicare Shared Savings Program that implicates the Physician Self-
Referral Law and fully complies with an exception at 42 CFR 411.355
through 411.357.
We also proposed to waive certain provisions of the Gainsharing CMP
with respect to two scenarios: (1) Distributions of shared savings
received by an ACO from CMS under the Medicare Shared Savings Program
in circumstances where the distributions are made from a hospital to a
physician, provided that the payments are not made knowingly to induce
the physician to reduce or limit medically necessary items or services,
and the hospital and physician are ACO participants or ACO providers/
suppliers, or were ACO participants or ACO providers/suppliers during
the year in which the shared savings were earned by the ACO; and (2)
any financial relationship between or among the ACO, its ACO
participants, and its ACO providers/suppliers necessary for and
directly related to the ACO's participation in and operations under the
Medicare Shared Savings Program that implicates the Physician Self-
Referral Law and fully complies with an exception at 42 CFR 411.355
through 411.357.
The Waiver Designs Notice recognized that the proposed waivers
might not cover all of the possible arrangements involved with setting
up and operating an ACO. As such, we solicited comments on waivers,
modifications, or additions that would be necessary to carry out the
provisions of the Shared Savings Program. We specifically solicited
comments on how waivers should address: arrangements related to
establishing the ACO; arrangements between or among ACO participants
and/or ACO providers/suppliers related to ongoing operations of the ACO
and achieving ACO goals; other arrangements for which a waiver would be
necessary; the duration of the waivers; and the scope of the waivers.
III. Summary of Public Comments to the Waiver Designs Notice and
Relevant Sections of the Shared Savings Program Proposed Rule
We received comments related to the proposed waivers and
solicitation of comments on other waiver design considerations in
response to both the Waiver Designs Notice and the Shared Savings
Program proposed rule. We summarize the comments in this section of the
IFC. Section V. of this IFC explains the waivers in more detail and
responds to comments.
A. Threshold Qualifications for Waiver
Commenters requested that we clarify whether we will be issuing
waivers that are uniform across all ACOs
[[Page 67996]]
participating in the Shared Savings Program. At least one commenter
recommended that we retain some provision for individualized review
while others requested that waivers apply uniformly to all
participants.
B. Scope of Proposed Waivers
We received numerous comments about the appropriate scope of the
waivers. The great majority of commenters supported broader waivers.
Many of those commenters indicated that the proposed waivers would be
insufficient to foster the innovation and relationships necessary for
participation in the Shared Savings Program. However, some commenters
expressed concern that the proposed waivers were too broad, or that
expanded waivers could lead to program abuses.
1. General Issues
Many commenters stated that the applicable fraud and abuse laws
should be waived in their entirety for ACOs participating in the Shared
Savings Program because, according to the commenters, the laws are
premised on a ``fee-for-service'' world that has different incentives
than those that apply to the Shared Savings Program and because the
Shared Savings Program incorporates monitoring, reporting, and other
program features that will act as safeguards. These commenters stated
that DHHS should waive these laws for entities that successfully enter
and participate in the Shared Savings Program, such that the entities
would be shielded from penalties for transactions related to ACO
business. Many commenters stated that certain elements of the Physician
Self-Referral Law exceptions and Federal anti-kickback statute safe
harbors cannot sufficiently support the development of innovative ACO
structures. For example, these commenters identified the ``transaction-
by-transaction'' structure of the existing exceptions and safe harbors
and the ``fair market value'' or ``set in advance'' elements of many of
them as specific burdens.
Several commenters stated that the fraud and abuse laws should be
waived for payments between ACOs enrolled in the Shared Savings
Program, their ACO participants, and/or their ACO providers/suppliers,
regardless of the source of funding for the payments. Some commenters
asserted that the Shared Savings Program's standards for clinical
integration should justify protection for payments other than shared
savings distributions, if the payments are made in service of achieving
Shared Savings Program goals. Others were concerned that the continued
use of fee-for-service payments in the program created an incentive for
overutilization.
The majority of comments generally suggested one of two broad
approaches to waiving the laws: First, an ``ACO waiver'' establishing
broad protections for ACO functions, or second, a total waiver of the
laws for any ACO participating in the Shared Savings Program. Many
commenters called for the agencies to create an ``ACO waiver'' that
would cover ACO activities through the lifespan of an ACO, from
arrangements leading up to formation of the ACO, through the end of the
ACO's participation in the program. Other commenters advocated the
creation of a ``single, comprehensive approach'' for compliance, rather
than requiring a piecemeal transaction-by-transaction analysis. Some
commenters requested ``blanket'' waivers for certain categories of
remuneration, including non-monetary arrangements (such as IT services,
EHR systems, and the provision of free care management personnel and/or
services) and ``systems-level'' activities (such as medical
directorships or infection prevention/antimicrobial stewardship
programs).
In contrast, a minority of commenters favored waivers no broader or
narrower than the proposed waivers. Some of these commenters advocated
alternate approaches including: Different safeguards (discussed later
in this IFC), waivers conditioned on certain qualitative limits, and
more extensive monitoring (including monitoring of beneficiary access
to care and cost-shifting to private insurers). Although some
commenters were concerned about an overly broad waiver and cautioned
against expanding beyond the proposed waiver designs, the majority of
commenters believed the proposed waiver for shared savings
distributions would be too narrow, particularly because an ACO, its ACO
participants, and its ACO providers/suppliers will not have access to
the shared savings distributions until long after the ACO has entered
into its participation agreement, thus precluding use of those savings
to fund start-up and operating activities.
Some commenters raised issues related to specific scenarios. For
example, a commenter requested that ACOs with ``commercial motives'' be
treated differently than ACOs composed of ``public health providers''
because, according to the commenter, the latter do not give rise to
similar fraud and abuse concerns. Other commenters stated that the
fraud and abuse laws presented a particular challenge for prospective
ACOs in States with ``corporate practice of medicine'' laws because
providers and suppliers could not satisfy certain important exceptions
and safe harbors (including the employment exception and safe harbor)
in those States.
We also received requests for clarification about the proposed
waivers. Several commenters requested clarification about how the fraud
and abuse laws would interact with specific Shared Savings Program
rules. For example, one commenter expressed concern about the phrase
``distributions of shared savings,'' and asked the agencies to clarify
whether a payment from an ACO to its ACO participants or its ACO
providers/suppliers must be conditioned on the same quality and cost
terms that govern the ACO's participation agreement (or whether it
would be sufficient that the payment initially comes from shared
savings). We also received a number of comments on the proposed
``necessary for and directly related to'' standard. Commenters
overwhelmingly requested that we clarify this phrase, arguing it was
too restrictive and thus did not provide sufficient assurance that ACOs
could participate in the Shared Savings Program. Some commenters
believed the standard was overly broad, with one expressing concern
that the standard could allow arrangements that would eliminate
competition. Some commenters requested concrete examples of
relationships that would meet this standard, while others requested
that the agencies allow greater flexibility. Commenters also suggested
a range of different standards, including, for example, mandating that
relationships simply be ``related'' or ``directly related'' to the ACO,
making the standard subjective, or requiring payments to entities
outside the ACO to be linked to quality improvement goals. Finally,
some commenters stated that it would be difficult to isolate
arrangements that are ``necessary for and directly related to'' the ACO
because many arrangements will only be feasible if applied to all
payers and/or patients.
Some commenters also raised questions about how the waivers would
function practically. For example, one commenter asked whether all ACO
participants or ACO providers/suppliers would endanger their Medicare
fee-for-service payments if the ACO (or one of its ACO participants or
ACO providers/suppliers) fails to satisfy one of the qualifications of
the waiver. We also received many requests for clarification of the
scope of the waiver for shared savings distributions. For example,
[[Page 67997]]
some commenters asked us to confirm that downstream distributions would
be covered by the waiver, while others asked us to clarify whether
repayment of start-up costs out of shared savings would be considered
``necessary for and directly related to'' the ACO's participation in
the program.
2. Compliance With the Physician Self-Referral Law Waiver
We received several comments asking for clarification of the
proposed waiver of the Federal anti-kickback statute and Gainsharing
CMP for financial relationships between or among the ACO, ACO
participants, and ACO providers/suppliers necessary for and directly
related to the ACO's participation in and operations under the Shared
Savings Program that implicate the Physician Self-Referral Law and
fully comply with an existing exception at 42 CFR 411.355 through
411.357. Several commenters requested expansion of this waiver to cover
relationships that would not implicate the Physician Self-Referral Law
either because the relationship would not involve designated health
services or would not involve referring physicians covered by the
Physician Self-Referral Law. While commenters on this topic generally
welcomed the alignment of the Federal anti-kickback statute, the
Gainsharing CMP, and the Physician Self-Referral Law for ACO
arrangements, some expressed concern that the proposed waiver design
was too limited to promote many innovative ACO arrangements.
3. Gainsharing CMP
Some commenters requested clarification of the application of the
waiver of the Gainsharing CMP. For example, some commenters asked us to
confirm that distributions of shared savings made from the ACO to a
physician would be protected, even if the ACO is owned in part by a
hospital. Some commenters urged us to adopt a narrow waiver of the
Gainsharing CMP and to carefully monitor ACOs to ensure that the waiver
does not lead to a reduction or limitation of medically necessary
services. Many commenters requested additional clarification of the
``medically necessary'' standard that limited application of the
proposed waiver of the Gainsharing CMP to arrangements that do not
reduce medically necessary care. Several commenters asked us to clarify
or confirm whether reliance on evidence-based protocols would be
sufficient to meet the ``medically necessary'' standard. Several
commenters noted that successful ACOs may reduce some types of
medically necessary services by encouraging the use or ordering of
alternative medically necessary services, for example, arrangements
that incentivize reductions in emergency room visits by encouraging
management of conditions on a non-emergency basis or arrangements that
reduce inpatient admissions in favor of coordinated outpatient care. A
commenter urged us to permit financial rewards that incent
implementation of evidence-based treatment protocols, even though such
payments may be intended to encourage clinicians to select one type of
medically necessary service over another.
C. Duration of Waivers
Commenters generally objected to the proposed requirement that the
waivers would apply only so long as an ACO, its ACO participants, and
its ACO providers/suppliers remained in compliance with Shared Savings
Program requirements. Some commenters requested that this requirement
be eliminated and replaced by a simpler threshold for waiver
qualification, asserting that the auditing and oversight functions at
the outset of and during the Shared Savings Program are sufficient to
protect against fraud and abuse.
Many commenters requested that the waivers cover periods prior to
an ACO's acceptance into the Shared Savings Program. Some of these
commenters also expressed a desire that the waivers cover time periods
after the ACO, its ACO participants, and its ACO providers/suppliers
have left the Shared Savings Program, for purposes of winding down the
arrangement or otherwise ensuring continued compliance with the laws.
One commenter suggested that the waivers cover a period of at least 24
months prior to the start of any agreement with CMS, with no
possibility of retroactive enforcement, in order to avoid a chilling
effect on innovation. Other commenters suggested that the agencies
apply the waivers to payments whenever made, if the payments relate to
activities leading up to or occurring within the agreement period.
D. Additional Waiver Design Considerations
1. Start-Up Costs
Many commenters stated that the fraud and abuse laws should be
waived in a manner that allows participants to finance others' start-up
costs. As examples, commenters identified: Infrastructure creation and
provision prior to acceptance in the Shared Savings Program (for
example, care coordination mechanisms; EHR systems; data reporting
systems; new staff; and systems to make operational performance
measurements and allocate performance results and payments
accordingly); market analysis for antitrust purposes; potential novel
arrangements created to facilitate integration across multiple
organizations; organizational and training costs; incentives to attract
primary care physicians; and any loans, capital contributions, grants
and withholds.
Some commenters suggested that waivers covering start-up costs
should be limited to providers that have a financial stake in the
success of the ACO, or, absent this requirement, that any waiver should
be limited to distributions of shared savings only.
2. Other Arrangements Among the ACO, Its ACO Participants, and Its ACO
Providers/Suppliers
Most commenters on this topic stated that waivers should cover
arrangements (in addition to those arising out of shared savings) among
the ACO, its ACO participants, and its ACO providers/suppliers. One
commenter recommended that the waivers not apply to additional
arrangements unless the arrangements are necessary for or directly
related to the ACO's operations under the Shared Savings Program. But
the majority of commenters, supporting a broader approach to waivers,
explained that waivers for other arrangements are necessary to allow
for start-up, operating, and maintenance costs in the context of
innovative arrangements. These commenters had various suggestions about
how the laws should be waived. As noted previously, many commenters
suggested that the fraud and abuse laws should be waived broadly for
ACOs in the Shared Savings Program. Others suggested that the laws
should be waived for compensation that is expressly conditioned on
quality improvements, cost savings, or adherence to objective clinical
measures, care coordination guidelines, and/or treatment models. Others
suggested that waivers should cover payments that are made in
connection with the operations and goals of the ACO and are
commercially reasonable. Some commenters asked us to consider
situations in which ACOs do not generate shared savings immediately, if
at all, and pointed to the Medicare Physician Group Practice
demonstration project as an example. One commenter proposed that the
waiver should cover hospitals that share the proceeds of system-wide
savings they achieve
[[Page 67998]]
outside the context of the Shared Savings Program or some other formal
payer-organized shared savings program.
3. Other Arrangements With Parties Outside the ACO
Some commenters asked us to clarify the term ``outside individuals
and entities'' as that term was used in the solicitation of comments on
this issue. For example, commenters asked whether the waivers would
cover arrangements with physicians and other providers who are not ACO
participants or ACO providers/suppliers but who treat ACO patients and
voluntarily comply with the ACO's policies and procedures.
Many commenters appreciated the proposed waiver for arrangements
with parties outside the ACO that are funded with distributions of
shared savings. However, many commenters requested that we expand the
waiver to cover arrangements with individuals or entities outside the
ACO even if the payments are not derived from shared savings. Some
commenters suggested that covered arrangements be restricted to those
that meet articulated standards (for example, only arrangements arising
out of the distribution of shared savings should be waived) and that
CMS monitor referrals to ensure that non-ACO participants and non-ACO
providers/suppliers are not being unfairly marginalized.
4. Relationships With Private Payers/Other Payers
Many commenters stated that the agencies should waive the fraud and
abuse laws for arrangements involving payments from private payers to
ACOs, including ``downstream'' arrangements between or among the ACO,
ACO participants, and ACO providers/suppliers. These commenters
generally believed that limiting the waiver to arrangements involving
Medicare shared savings would limit economies of scale and introduce
significant complexity from the perspective of governance and
management. One commenter argued that the involvement of private health
plans in ACO relationships would reduce fraud and abuse concerns. Some
commenters expressed concern that failure to address private payer
arrangements would perpetuate uncertainty for ACOs enrolling in the
Shared Savings Program that were also contemplating similar
arrangements with private payers. These commenters observed that
arrangements downstream of private payer incentive payment programs can
be sensitive to the volume or value of ``other business generated'' for
providers and suppliers and thus might not fit in existing exceptions
to the Physician Self-Referral Law. One commenter representing health
plans expressed concern about ACO arrangements under the Shared Savings
Program that might result in cost-shifting to private plans or steerage
of patients to or from Medicare managed care plans based on the
services required by the patient. Some commenters stated that we should
not create waivers for private payer arrangements.
Some commenters suggested that, if the final waivers do not cover
relationships with private payers, the agencies should clarify how
elements of existing exceptions and safe harbors may be applied to such
arrangements involving ACOs. For example, commenters requested further
clarification on the following: whether hospital distribution of a
private payer's shared savings payments would constitute ``indirect
compensation'' under the Physician Self-Referral Law; how to calculate
``fair market value'' of downstream distributions of private payer
shared savings for purposes of applicable exceptions; and whether the
Physician Self-Referral Law risk-sharing exception could be used.
Finally, one commenter requested that the agencies integrate guidance
for private payers with guidance for other non-Medicare payers,
including Medicaid.
5. Appropriate Safeguards
Some commenters stated that safeguards beyond the transparency,
accountability, and oversight protections built into the Shared Savings
Program proposed rule are unnecessary because such safeguards
adequately address patient and program abuse. A commenter stated that
providing opportunities for creativity without waiver-specific,
restrictive safeguards will not increase the likelihood that
individuals or organizations will place their own financial interests
above those of their patients; instead, it will allow them to focus on
furnishing appropriate and necessary care coordination. A commenter
suggested that safeguards be based on prior OIG advisory opinions or
the CMS proposed incentive payment and shared savings exception.
Other commenters believed that additional safeguards are necessary
and suggested, for example, requiring arrangements to meet a fair
market value or commercial reasonableness standard; requiring
additional disclosures to CMS and to patients; or imposing more
specific requirements related to methods for distributing shared
savings to address the commenters' concerns about distributions
inappropriately influencing physician ordering patterns or possible
stinting on care.
A commenter stated that the waiver for shared savings distributions
should not protect distributions of shared savings from an ACO to an
ACO participant on the basis of that ACO participant's generation of
other business for another ACO participant. Some commenters suggested
monitoring of referrals outside the ACO to detect improper referral
patterns. One commenter requested that CMS create a system to
continually assess the compliance of an ACO, its ACO participants, and
its ACO providers/suppliers with the fraud and abuse laws.
6. Two-Sided Risk
We received several comments in response to our solicitation on
waiver considerations related to two-sided risk. One commenter noted
that a waiver should apply equally to both one- and two-sided risk
models. Other commenters recommended that CMS either extend the
proposed waiver to cover hospitals' disproportionate assumption of risk
or change the Shared Savings Program proposed rule to make the two-
sided option voluntary or make it clear that such assumption of risk is
not remuneration under the Physician Self-Referral Law. Commenters
asked that we protect the means or allocation of shared savings and
losses, and that we define the ``proper'' allocation of such savings or
losses.
7. Existing Exception and Safe Harbor for Electronic Health Records
We sought comments in the Waiver Designs Notice addressing whether,
in connection with the Shared Savings Program, we should use the
authority at section 1899(f) of the Act to waive the Physician Self-
Referral Law and the Federal anti-kickback statute for ACO arrangements
that satisfy the existing exception and safe harbor \6\ for EHR
arrangements but that are expected to occur after the sunset date of
2013. Some commenters requested that the agencies waive the current
sunset date of 2013 that applies to the existing EHR exception and safe
harbor, and suggested that the agencies protect the EHR arrangements of
ACOs in the Medicare Shared Savings Program after 2013 on the same
terms as the existing exception and safe harbor. Some commenters
particularly argued that the Shared Savings Program proposed rule's
standard of 50 percent meaningful use
[[Page 67999]]
of EHRs demonstrated the need to extend the waiver to relationships
intended to reach that standard.
---------------------------------------------------------------------------
\6\ 42 CFR 411.357(w) and 42 CFR 1001.952(y), respectively.
---------------------------------------------------------------------------
One commenter disagreed with waiving the EHR exception and safe
harbor and suggested rescinding the exception and safe harbor or
specifically excluding these types of arrangements from the waiver,
because the EHR incentive in American Recovery and Reinvestment Act of
2009 was sufficient to achieve the exception's and safe harbor's
original purpose of promoting adoption of technology. However, most
commenters addressing this topic requested that we make the exception
and safe harbor permanent, extend them for several years, or protect
ACOs at any time after the sunset on the same terms as the exception
and safe harbor.
8. Beneficiary Inducements
Most commenters addressing this topic supported a waiver of the
Beneficiary Inducements CMP, section 1128A(a)(5) of the Act, although
some of them expressed opposition. Among commenters supporting a
waiver, many cited the need for a waiver to promote greater preventive
care, to incentivize patients to follow treatment or follow-up care
regimes, and to increase participation in ACOs in order to achieve the
goals of the Shared Savings Program. Several supporters of a waiver
suggested that the waiver cover reduced or eliminated beneficiary cost-
sharing, or other financial incentives, such as allowing beneficiaries
to share in ACO cost savings. Commenters opposing a Beneficiary
Inducements CMP waiver stated it could negatively impact patient choice
by promoting incentives that might induce beneficiaries to seek care
only within a particular ACO.
9. Timing of Waivers
Generally, commenters supported issuance of the waivers prior to or
at the same time as the Shared Savings Program final rule in order to
afford prospective ACOs, their ACO participants, and ACO providers/
suppliers as much time as possible to prepare for application to the
Shared Savings Program with known waiver protection.
10. Other Issues Related to Shared Savings Program Waivers
Commenters raised a number of other issues related to the waivers.
Some commenters requested that the waivers apply to clinically
integrated organizations that do not participate in the Shared Savings
Program. Others raised the issue that waivers of the Physician Self-
Referral Law, Federal anti-kickback statute, and Gainsharing CMP laws
do not offer protection with respect to State laws. Several commenters
asked the agencies to clarify how the proposed waivers would affect
programs outside the Shared Savings Program. Commenters proposed that
CMS should extend uniform waivers for all Medicare projects involving
coordinated care, including the Independence at Home project, Bundled
Payment project, and demonstrations sponsored by the Innovation Center.
One commenter requested that the waiver apply to healthcare providers
other than ACO participants or ACO providers/suppliers, while others
requested that waivers apply to all arrangements between ACO
participants and/or ACO providers/suppliers, and individuals or
entities outside the Shared Savings Program.
We also received a number of comments that are outside the scope of
this rulemaking. Those comments are not summarized here.
IV. Provisions of the Interim Final Rule With Comment Period: Waiver
Requirements
A. Overview
Section IV.B. of this IFC sets forth the specific waivers and
waiver requirements, pursuant to the authority granted under section
1899(f) of the Act. The waivers apply only to the specific provisions
of the laws enumerated in the waivers and do not apply to any other
provisions of Federal or State law, including, without limitation, any
provisions of the IRC. We invite the public to comment on the waivers
set forth in section IV.B. of this IFC.
To promote efficiency and ease of use, we crafted the waivers to
apply consistently across the waived fraud and abuse laws to the extent
possible. The waivers apply uniformly to each ACO, ACO participant, and
ACO provider/supplier (as those terms are defined in section IV.B. of
this IFC pursuant to the Shared Savings Program) participating in the
Shared Savings Program. The waivers are intended to be self-
implementing. Apart from meeting applicable waiver conditions, no
special action (such as the submission of a separate application for a
waiver) is required by parties in order to be covered by a waiver.
Parties need not apply for an individualized waiver.
This IFC includes five waivers. The multiplicity of waivers is
intended to afford flexibility to ACOs in varying circumstances and to
be responsive to public comments outlining a wide variety of
arrangements that ACOs of various types might need to undertake in
order to be successful at carrying out the Shared Savings Program.
While the waivers contain many common elements, there are distinctions
among them tailored to address particular circumstances, including
particular fraud and abuse risks. The first two waivers are an ACO pre-
participation waiver and an ACO participation waiver that should,
collectively, address the majority of ACO-related start-up and
operating arrangements identified by public comments and the DHHS's own
analysis as necessary to carry out the Shared Savings Program. Two
additional waivers--for shared savings distributions and arrangements
that are in compliance with the Physician Self-Referral Law--were
described in the Waiver Designs Notice and are being established in
this IFC with minor modifications. Many arrangements covered by these
waivers could also be protected under the ACO pre-participation and ACO
participation waivers. However, some parties may find these two
additional waivers more suitable to their particular needs, and we have
elected to make them available. The remaining waiver addresses
incentives offered to beneficiaries to foster preventive health care
and patient compliance with treatment regimes in order to engage
patients in quality and care improvement. For ease of reference, the
entire set of waivers and applicable requirements is set forth in
section IV.B. of this IFC. We will also make the waiver text available
on both the CMS and OIG Web sites. Because the waivers cover multiple
legal authorities and to ensure that the waivers, if modified, remain
consistent over time and across relevant laws, we are not codifying the
waivers in the Code of Federal Regulations. We solicit comments about
this approach.
Additional explanation appears in section V. of this IFC, as well
as additional solicitations of comments on possible modifications to
the waiver designs.
B. The Waivers and Applicable Requirements
As used in these waivers, ACO, ACO participant, and ACO provider/
supplier have the meanings set forth in 42 CFR 425.20. In the context
of the ACO pre-participation waiver, these terms refer to individuals
or entities that would meet the definitions of the terms set forth in
42 CFR 425.20, if the ACO had a participation agreement, but for the
fact that the ACO has not yet submitted the list required under 42 CFR
425.204(c)(5) to be provided with the application for the Shared
Savings Program.
[[Page 68000]]
As used in these waivers, participation agreement refers to the
agreement between an ACO and CMS for the ACO's participation in the
Shared Savings Program that is described in 42 CFR 425.208.
As used in these waivers, purposes of the Shared Savings Program
means one or more of the following purposes consistent with section
1899(a) and (b) of the Act: promoting accountability for the quality,
cost, and overall care for a Medicare patient population as described
in the Shared Savings Program, managing and coordinating care for
Medicare fee-for-service beneficiaries through an ACO, or encouraging
investment in infrastructure and redesigned care processes for high
quality and efficient service delivery for patients, including Medicare
beneficiaries.
As used in these waivers, start-up arrangements means any items,
services, facilities, or goods (including non-medical items, services,
facilities, or goods) used to create or develop an ACO that are
provided by such ACO, ACO participants, or ACO providers/suppliers.
ACO Pre-participation Waiver. Pursuant to section 1899(f) of the
Act, section 1877(a) of the Act (relating to the Physician Self-
Referral Law), sections 1128A(b)(1) and (2) of the Act (relating to the
Gainsharing CMP), and sections 1128B(b)(1) and (2) of the Act (relating
to the Federal anti-kickback statute) are waived with respect to start-
up arrangements that pre-date an ACO's participation agreement,
provided all of the following conditions are met:
1. The arrangement is undertaken by a party or parties acting with
the good faith intent to develop an ACO that will participate in the
Shared Savings Program starting in a particular year (the ``target
year'') and to submit a completed application to participate in the
Shared Savings Program for that year. The parties to the arrangement
must include, at a minimum, the ACO or at least one ACO participant of
the type eligible to form an ACO (as set forth at 42 CFR 425.102(a)).
The parties to the arrangement may not include drug and device
manufacturers, distributors, durable medical equipment (DME) suppliers,
or home health suppliers.
2. The parties developing the ACO must be taking diligent steps to
develop an ACO that would be eligible for a participation agreement
that would become effective during the target year, including taking
diligent steps to meet the requirements of 42 CFR 425.106 and 425.108
concerning the ACO's governance, leadership, and management.
3. The ACO's governing body has made and duly authorized a bona
fide determination, consistent with a duty to the ACO that is
equivalent to the duty owed by ACO governing body members under 42 CFR
425.106(b)(3), that the arrangement is reasonably related to the
purposes of the Shared Savings Program.
4. The arrangement, its authorization by the governing body, and
the diligent steps to develop the ACO are documented. The documentation
of the arrangement must be contemporaneous with the establishment of
the arrangement, the documentation of the authorization must be
contemporaneous with the authorization, and the documentation of the
diligent steps must be contemporaneous with the diligent steps. All
such documentation must be retained for at least 10 years following
completion of the arrangement (or, in the case of the diligent steps,
for at least 10 years following the date the ACO submits its
application or the date the ACO submits its statement of reasons for
failing to submit an application, as described in item 6) and promptly
made available to the Secretary upon request. The documentation must
identify at least the following:
a. A description of the arrangement, including all parties to the
arrangement; the date of the arrangement; the purpose(s) of the
arrangement; the items, services, facilities, and/or goods covered by
the arrangement (including non-medical items, services, facilities, or
goods); and the financial or economic terms of the arrangement.
b. The date and manner of the governing body's authorization of the
arrangement. The documentation of the authorization should include the
basis for the determination by the ACO's governing body that the
arrangement is reasonably related to the purposes of the Shared Savings
Program.
c. A description of the diligent steps taken to develop an ACO,
including the timing of actions undertaken and the manner in which the
actions relate to the development of an ACO that would be eligible for
a participation agreement.
5. The description of the arrangement is publicly disclosed at a
time and in a place and manner established in guidance issued by the
Secretary. Such public disclosure shall not include the financial or
economic terms of the arrangement.
6. If an ACO does not submit an application for a participation
agreement by the last available application due date for the target
year, the ACO must submit a statement on or before the last available
application due date for the target year, in a form and manner to be
determined by the Secretary, describing the reasons it was unable to
submit an application.
For arrangements that meet all of the preceding conditions, the
pre-participation waiver applies as follows:
The waiver period would